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According to World Health Organization, cardiovascular disease is the leading global cause of death, 
accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million 
by 2030. Of these deaths, an estimated 7.4 million were due to coronary heart disease. Acute coronary 
syndrome(ACS) is a sudden and severe heart condition that may lead to death [1]. It is usually the 
manifestation of coronary atherosclerosis, a systemic inflammatory disease causing the formation of 
plaques [2,3]. ACS is usually associated with the thrombus formation as a result of the rupture of a 
lipid-core lesion [3,4]. Previous studies have shown that 60% of the thrombi associated with the acute 
coronary events had a ruptured thin cap fibroatheroma (TCFA) as their substrate [3]. The TCFAs are 
typically characterized by a large necrotic core with a thin cap, probably infiltrated by macrophages [5]. 
The combination of the inflammation due to the macrophage infiltration and the mechanical strain in 
the TCFAs make them unstable or ‘vulnerable’ plaque prone to rupture [6-8]. Early detection of these 
high risk plaques may have important clinical impact on the prevention of acute cardiac events. 
Percutaneous coronary intervention (PCI) also known as coronary angioplasty, is an effective non-
surgical procedure for treating severe coronary artery disease. It is a minimally invasive method that is 
done using x-ray angiographic guidance. The procedure involves introduction of a steerable guide wire 
into coronary artery and across the stenosis through the femoral, radial or brachial arteries. The balloon 
or stent catheter is passed over it and the lesion dilated and/or stented. Figure 1.1 shows the procedure 
and an example frame from angiography.
Traditionally coronary angiography has been the tool for morphological assessment in stent placements. 
The drawback of angiography is that it can only measure the luminal stenosis which may be the result 
of a rupture but do not visualize the vessel wall where the atherosclerosis, the cause of the disease, 
may exist. It does not visualize, therefore, the lipid core plaques which have important implications 
during intervention, as incomplete coverage of them by stent could lead to immediate or long-term 
complications [9-13]. Also the measurements can be ambiguous at times due to the projection and low 
resolution. 
1.1 | Intravascular imaging
Intravascular imaging techniques have emerged as useful clinical morphological tools. Intravascular 
ultrasound (IVUS), intravascular optical coherence tomography (IV-OCT), intravascular photoacoustics 
(IVPA) and coronary angioscopy are few intravascular imaging tools. These are catheter based 
techniques that provides a tomographic view from inside the lumen. Some of them have also been tried 
to extend their usability by adding diagnostic values like tissue composition information. IVUS-Virtual 
histology (VH), IVUS palpography, coronary angioscopy, near-infrared spectroscopy (NIRS) with 
IVUS, spectroscopic IVPA and OCT attenuation imaging have been studied for potential intravascular 
diagnostic imaging [14-18]. Few of the intravascular imaging techniques are described below.
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Figure 1.1 | a) The cartoon depicts the PCI procedure (Source: medifitbiologicals.com) b) A frame from 
angiography showing a high risk stenosis in the left anterior descending artery.
1.1.1 | Intravascular Ultrasound
Ultrasound images are formed by electrically exciting a piezoelectric transducer, which expands and 
contracts to produce sound waves. The backscattered ultrasound energy from the tissue is received by 
the transducer which produces electrical signals that is converted into the image [19]. In intravascular 
ultrasound imaging a high frequency ultrasound transducer is placed on the tip of a catheter which 
is directly inserted into the blood vessel to obtain reproducible and high resolution images. Typical 
resolution of a 20 to 40 MHz IVUS transducer is 80 microns axially and 200 to 250 microns laterally. 
1.1.2 | Near-infrared spectroscopy 
Near-infrared spectroscopy (NIRS) uses spectral signature to determine the chemical composition 
of substances. Spectroscopic assessment of the arterial plaque by NIRS has the potential to identify 
Lipid core plaque (LCP) in patients. In the commercial system NIRS is combined with IVUS for 
morphological information. The NIRS-IVUS images are acquired using a hybrid optical/ultrasound 
catheter [16,20]. The instrument performs approximately 8000 chemical measurements per 100 mm 
of artery scanned. An automated pullback (0.5 mm/sec and 16 frames per second (fps)) acquires co-
registered images of measured probability of LCP presence by NIRS, displayed as a color-coded ring 
(yellow is high probability, red is low), and gray-scale IVUS. The measurement of the probability of LCP 
for each scanned arterial segment is displayed as a map, with the x-axis indicating the pullback position 
in millimeters and the y-axis the circumferential position of the measurement in degrees. 
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Figure 1.2 | a) A cross section image of an artery by NIRS-IVUS depicting the probability of the presence of lipid 
as a ring around the gray scale IVUS b) The “chemogram” depicting the probability of lipid in the entire vessel.
1.1.3 | Intravascular Optical Coherence tomography 
Intravascular OCT is gaining popularity as the clinical tool for stent assessment and optimization. OCT 
is technique that uses infrared light to provide high resolution images of the artery wall and implanted 
stents [21-23]. The imaging is catheter based, so the free lumen is seen as opposed to a projection in 
angiography and the landing zones for the stents can be better assessed. This is important information 
in image guided intervention for better results and future outcomes. Also a recent study suggests that 
OCT guided PCIs have significantly better outcome than those done with angiographic guidance alone 
[24,25]. 
Figure 1.3 | a) An angiographic image showing a section with a sidebranch (I) and a section with stenosis (II) 
(b&c) corresponding OCT image of the sections (I&II) showing the tomographic view. 
503688-L-sub01-bw-Gnanadesigan
1
11Introduction | 
1.1.3.1 | Principle
OCT is a low coherence interferometric technique where images are formed as a result of an interference 
pattern of the reflected light from a reference and sample arm, illustrated in Figure 1.4. When the 
first generation of OCT (using time-domain scanning) was first demonstrated in the early 90s, the 
reference arm was moved mechanically. In one dimensional tissue scattering model, the spatial extent 
of temporal coherence function of the source determines the axial width of the point-spread function 
therefore, the coherence length is an appropriate measure of the axial resolution of the OCT system 
[26]. Later the mechanical scanning was replaced by frequency scanning using a swept source laser in 
the next generation frequency domain system (FD-OCT) [27-29]. These FD OCT systems have a much 
improved imaging speed and signal to noise ratio [30,31]. IV-OCT uses a single mode fiber in a catheter 
in the sample arm, the light from which is reflected towards the arterial wall by a prism or mirror. The 
backscattered light from the tissue results in an A-line that represents the depth-resolved reflectivity 
profile of the tissue components. When the optical fiber in the catheter is rotated a complete image scan 
of the artery is obtained and this when combined with a pullback of the fiber results in a volumetric scan 
of the artery. 
Figure 1.4 | Swept source OCT principle and a typical commercial OCT system and catheter (www.sjm.com). 
SS-swept source, BS-beam splitter, REF-reference mirror, SMP-sample, PD-photodetector, DSP-digital signal 
processing
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The axial resolution of OCT depends on the sweeping length of the laser source. Typically the axial 
resolution is around 10 µm. The transverse resolution is based on the spot size of the laser beam at the 
focal point and is typically it is ~30 µm. The frame pitch or the frame spacing of OCT is about 200 µm. 
During interventions, the artery to be imaged has to be flushed with a clear medium as the blood highly 
attenuates light. Usually a contrast medium is used for flushing and the pullback is done at the speed of 
20 mm/sec.
 
1.1.3.2 | Potential uses
Currently OCT is used extensively for guidance in stent implantation. It can provide accurate lumen 
measurements at the stenosis, the measurements in the proximal and distal landing zones and the 
segment to be stented. The high-resolution images of the arterial wall allows for qualitative interpretation 
of its composition [32-35]. This can help in the preventing the incomplete coverage of the lipid core 
plaques as discussed above [36]. Figure 1.5 shows OCT images of a few cross sections of the artery and 
the annotations show the qualitative interpretation based on the consensus standard. 
Figure 1.5 | a) OCT cross-section with a fibrotic plaque marked by *. The fibrous plaques have low attenuation 
coefficients and high backscattering properties. b) An OCT frame with a chunk of calcium denoted by the 
marker. They are usually exhibit low attenuation and low backscattering properties. c) A OCT cross-section 
with fibroatheroma (thick cap) as shown by the marker. The lipid content and possible necrosis results in high 
attenuation and low backscattering. d) A OCT image with a Thin-cap fibroatheroma (TCFA) as shown by the 
marker. These unstable plaques have characteristic very high backscattering superficially followed by very high 
attenuation owing to the lipid, necrosis content and the macrophage infiltration.
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OCT can be a more useful and easy diagnostic tool if the qualitative tissue characterization can be 
quantified and made simple to read. Parametric imaging of the attenuation can be a useful tool to 
achieve that. The increase in popularity of OCT in stent implantations and increase in the usage of 
the recently introduced bioresorbable vascular scaffolds which warrants the use of OCT for optimal 
placement, means adding diagnostic value to OCT is a very effective way to proceed. 
1.1.3.3 | Parametric imaging
The qualitative interpretations of plaque type are based on the appearance of the tissue constituents and 
their interaction with light. Different tissue types depict different optical properties and these properties 
can be quantified from the OCT images. The quantification of OCT-derived tissue optical properties has 
been proposed to automate tissue characterization. One of the optical properties that can be derived is 
the attenuation coefficient of a tissue type. Different tissue types attenuate light to different degree and 
the attenuation coefficient is a robust tissue optical parameter that can be used for tissue characterization 
or at the least support image interpretation [18,37-39]. Such analyses have recently been augmented with 
statistical image metrics to achieve tissue identification [40].
The expected value of the backscattered signal of OCT can be modeled using a single scattering 
model [41]. This model describes the signal as Beer-Lambert decay multiplied by coupling factor i.e. 
the longitudinal point spread function (PSF) for a single mode fiber (SMF) and a Gaussian coherence 
function to account for the signal roll off eqn 1-3.
  ‹Id(r)›=I0t(r)Ŝ(e)e(-μtr), (1)
  
  T(r)=[(   )2+1]r–z0zR
1
2
, (2)
 
  Ŝ(r)=e
–(     )2r–zczw . (3) 
where ‹Id(r)› is the expected value for the detected OCT signal. T(r) is the point spread function for 
the SMF based OCT system, and Ŝ(r) describes the signal roll off with depth [42]. The important 
parameter to be extracted is µt, which is the optical attenuation coefficient [18]. When eq. 1 is linearized 
by logarithmic compression, it yields
  log[‹Id(r)›]–log[T(r)]–log[Ŝ(r)]=log(I0)–μtr (4) 
The log compressed OCT intensity data from the measurement can be fitted in the above model. If the 
left hand side of eq. 4, the log compressed data compensated for the roll off and point spread function, 
can be denoted as id then it can be least-squares fitted with a linear model eq. 5,
   i(r)=log(I0)–μtr, (5) 
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The attenuation coefficient µt can be extracted from data by fitting them in the model in a window 
of variable length. The optimization of the fitting determines the window length for preserving 
homogeneity. This is a fast, reliable and robust method for parametric imaging. Such an attenuation 
image overlaid on the grayscale OCT image is shown in Figure 1.6.
Figure 1.6 | An OCT cross sectional image (left) and its corresponding attenuation image (right) derived from the 
model. The marker denotes a fibroatheromatic plaque with inflammation which has high attenuation as expected. 
The colorbar shows the low to high attenuation colors.
There have been studies using different approaches other than the attenuation coefficient for tissue 
characterization some of which are automatic and others semi-automatic. An automatic classification 
using texture analysis, automatic thresholding and classification algorithm has been demonstrated [43]. 
Correlating the bright spots to macrophages and using normalized standard deviation for macrophage 
quantification has been studied [44,45]. Also a semi-automatic segmentation and quantification of 
calcified plaques was shown before [46].
Plaques with a lipid-rich necrotic core are generally considered to be high-risk lesions, and may require 
special care in planning or performing PCI. Such plaques with macrophage infiltration usually exhibit 
high attenuation compared to calcium or fibrous tissue types [17]. Identifying these fibroatherotic 
plaques is an important aim for tissue characterization and if possible to distinguish thin and thick cap 
fibroatheromas, which could be clinically relevant. The parametric imaging can be a very useful tool if it 
can be demonstrated to be reliable predictor of the presence of unstable TCFAs. 
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1.2 | Thesis outlines
A quantitative measurement of IV-OCT can be a potential tool for atherosclerotic tissue characterization. 
We propose the tissue dependent parameter of OCT, the attenuation coefficient, as the quantitative 
measure for tissue characterization. In this thesis we did ex and in-vivo validation of attenuation imaging 
as a tissue characterization tool and demonstrated some of its clinical research utilities.
Chapter 2 shows the study of the effects of temperature and fixation on the attenuation coefficients of 
the ex-vivo tissues. The developed en-face maps of attenuation of the arteries at different conditions were 
systematically compared. 
Chapter 3 describes the IPA, a bias free and reproducible summary measurement of attenuation, as a 
lipid core detection tool. The IPA was qualitatively assessed for the sensitivity of lipid and was compared 
against the manual lipid score in OCT images.
Chapter 4 describes the clinical study aimed to validate the attenuation imaging as a plaque 
characterization tool in-vivo. The quantitative attenuation measure, the IPA, was compared against 
LCBI of near infra-red spectroscopy for detecting lipid. The ability to differentiate thin and thick cap 
fibroatheroma was demonstrated which can be a potential clinical utility.
Chapter 5 describes a qualitative comparative study of some of the available methods of tissue 
characterization in OCT. The different algorithms were performed on a set of ex-vivo data. The value of 
each method to the atherosclerotic tissue characterization is demonstrated.
Chapter 6 presents the first in-vivo long term OCT data after 5 years of implantation. The long-term 
vascular response was studied and the attenuation imaging depicts the newly formed adluminal sealing 
layer formed by the plaque underneath the disappeared struts.
Chapter 7 describes the study to evaluate dynamic changes of coronary atherosclerosis under standard 
medical therapy. A comprehensive patient-level and segment-level analysis of non-culprit lesions were 
done. The automated attenauation analysis was used to study objectively the plaque morphology.
Chapter 8 presents the study to evealuate the relationship between plaque free wall measured in OCT 
and the plaque burden measured in IVUS. The ability of OCT as morphological and diagnostic tool is 
demonstrated.
Chapter 9 summarizes the main findings of the thesis and their potential clinical implications.
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Effect of temperature and fixation on the optical 
properties of atherosclerotic tissue: a validation study 
of an ex-vivo whole heart cadaveric model 
Muthukaruppan Gnanadesigan, Gijs van Soest, Stephen White, Simon Scoltock, 
Giovanni J Ughi, Andreas Baumbach, Antonius FW van der Steen, Evelyn Regar, 
and Thomas W Johnson
Biomed Opt Express 5, 1038-1049 (2014).
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Abstract
Atherosclerotic plaque composition can be imaged using the optical attenuation coefficient derived from 
intravascular optical coherence tomography (OCT) data. The relation between optical properties and 
tissue type has been established on autopsy tissues. In this study, we validate an ex-vivo model for the 
effect of temperature and tissue fixation on optical parameters. We studied the optical attenuation of 
human coronary arteries at three temperatures, before and after formalin fixation. We developed an en-
face longitudinal display of attenuation data of the OCT pullbacks. Using the unfixed, body-temperature 
condition image as a standard, and after extensive registration with other condition images, we quantify 
the differences in optical attenuation and the backscattered intensity. The results suggest that tissue 
fixation and temperature do not introduce systematic errors in studies of arterial optical properties.
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2.1 | Introduction
Ischemic heart disease is a major cause of death globally and rupture of vulnerable atherosclerotic 
plaques, precipitating myocardial infarction, is the largest contributor to the phenomenon [1]. A 
vulnerable plaque commonly consists of a lipid-rich necrotic core contained by a fragile layer of fibrous 
tissue that can be compromised by inflammation and mechanical forces [2]. Release of the necrotic 
material into the bloodstream may cause thrombus formation leading to a myocardial infarction. Hence, 
the tissue composition of the plaque is an important predictor of its vulnerability [3]. Likewise, the 
presence of a lipid-core in a plaque may have an adverse effect on outcome of coronary interventions [4-
6]. Intravascular optical coherence tomography (OCT) is gaining widespread use in the interventional 
cardiology community for guidance of stent placement and optimization [7-10]. OCT facilitates high 
resolution imaging of the atherosclerotic plaque and tissue components can be distinguished to ascertain 
plaque composition [8,11,12]. The contrast of tissue types derives from differences in optical properties 
of the tissues in the artery wall, which can be quantified for tissue characterization in OCT images. The 
attenuation coefficient has been a popular metric to achieve this [13,14]: necrotic core and inflammation, 
associated with plaque vulnerability, have high attenuation compared to fibrous and calcified tissues 
[15].This finding is currently being clinically validated and appears to be robust in vivo [16]. The analysis 
has recently been augmented with statistical image metrics to achieve better specificity [17].
Validation of tissue characterization requires comparison of the optical attenuation against histological 
analysis of atherosclerotic tissue specimens; currently this can only be achieved using ex-vivo models. For 
ease of processing and analysis ex-vivo specimens of atherosclerotic tissue are commonly dissected from 
the myocardium, fixed with formalin and kept at low temperature for preservation. The effects of such 
processing on the acoustic properties of tissue have been studied extensively [18-23]. The knowledge of 
effects of such processing on tissue optics in the artery wall however is very scarce [24]. In comparison 
with in-vivo assessment of optical attenuation, refrigeration and fixation of tissue may significantly 
alter the optical attenuation characteristics of lipid and cellular components of atherosclerotic plaque. 
Assessment of the impact of temperature and fixation on the optical attenuation of atherosclerotic tissue 
is necessary to validate our ex-vivo whole heart cadaveric model, thereby facilitating translation into the 
clinical arena.
The assessment of the effect of temperature and fixation on optical attenuation requires co-registration 
of multiple OCT attenuation datasets, across varying conditions. It is important to recognize that 
accurate co-registration of OCT images is limited by a number of factors. Firstly, the helical rotation of 
the imaging probe during an OCT pullback combined with a narrow lateral width of imaging results 
in longitudinal under-sampling [25]. Furthermore, non-uniform rotation of the catheter, catheter 
movement and anatomical distortion can lead to misalignment of datasets. 
The aim of this study is to assess the effect of temperature and fixation on optical attenuation in an ex-
vivo whole heart cadaveric model, thereby facilitating development of a novel method of intra-vascular 
OCT tissue characterization.
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2.2 | Materials and methods
2.2.1 | Tissue handling and imaging procedure
The ex-vivo model we used consists of a whole heart cadaveric specimen obtained from the Valve Bank 
of West-England within 48 hrs from post-mortem and stored at or below 4°C [26]. The heart specimen 
was mounted in a set up as shown in Figure 2.1. A short guide catheter was introduced into the right 
coronary artery and fixed in position with sutures. All tissues were handled in accordance with the 
local ethics regulations. The cadaveric specimen is held within a purpose-built Perspex container, with 
adaptors on both sides of the container’s lid allowing connection of the guide catheter internally, and a 
Y-connector and pressure/injector manifold externally.
The OCT system used for imaging was a C7-XR with Dragonfly catheter (St. Jude Medical Inc. St. 
Paul, MN, USA). Pullback OCT imaging of one of the three major coronary arteries was performed 
at a pullback speed of 20 mm/s. The end of the guide catheter served as a reference point to relate the 
different pullback data sets longitudinally.
Three different temperature conditions were induced in the vessel by flushing with phosphate buffered 
saline (PBS) solution at 4°C, 20°C, and 37°C, resulting in tissue temperatures of 5-8°C (cold), 18-21°C 
(room temperature) and 35-37°C (body temperature). A needle-probe thermometer (Water resistant 
thermometer, Traceable®, VWR International, LLC) was inserted into the peri-adventitial tissue of the 
coronary artery and imaging was delayed until steady state temperature was achieved. During imaging, 
intracoronary pressure was maintained at 100 mmHg. OCT imaging was undertaken at these three 
temperatures. Subsequently, the tissues were pressure fixed with buffered formalin at 100 mmHg for 
15 minutes, preserving vessel morphology, and typically 500 ml of formalin was perfused into the heart, 
which was left in situ overnight at 4°C. The next day, a new temperature series was collected in the fixed 
tissue, creating a dataset of 6 different conditions. A total of 6 coronary arteries were imaged for the 
study.
After imaging the formalin fixed series, the study vessel was excised from the heart, fixed for a further 
24 hours, embedded in paraffin, and cut into 4-mm blocks. The end of the guide catheter served as a 
reference. The end face of each block is serially sectioned into slices of 3 µm thickness and stained for 
histologic analysis. In case of extensive disease seen on OCT, serial sections through the entire tissue 
block are generated. OCT data were matched to the histology cross-sections based on longitudinal 
position and general anatomy (side branches and presence of plaque).
In the description of the results in this paper we will adopt the following labels: data acquired on unfixed 
tissues will be designated by “U”; on fixed tissues by “F”. The temperatures will be indicated by “C” for 
cold, “R” for room, and “B” for body temperature. For example, our base condition of unfixed tissue at 
37°C will be referred to as “UB”.
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Figure 2.1 | Whole heart cadaveric model; the arrow points to the guide catheter that is fixed in the study vessel.
2.2.2 | Parameter extraction
The OCT images are then analyzed, to quantify the attenuation exhibited by the tissues. We derive the 
attenuation co-efficient from the OCT signal by fitting a single scattering model [15]:
  ‹Id›=T(r)∙S(r)∙I0∙e-μtr (1)
where T(r) is the point spread function of the catheter [27], S(r) is the signal roll-off, and the parameter 
of interest is µt, the attenuation coefficient. The attenuation calculation and the model implementation 
were done in Matlab Release 2012b (The Mathworks, Inc., Natick, MA, USA). The model is fitted in the 
polar image, in every A-line starting from the edge of the lumen [15,28], in small windows of varying 
length to extract the attenuation coefficients. The accuracy of the extracted µt is approximately 1 mm-1 
[15]. The data analysis results in an attenuation image per cross section of the pullback.
2.2.3 | Image formation and registration
In every vessel in the study, attenuation data sets are generated in six different conditions, resulting in six 
data sets that need to be registered for comparison. As a first step, the variation in the angle of view of a 
structure due to the different positioning of the catheter in different pullbacks should be compensated. 
To do so, the polar attenuation image is converted to the Cartesian domain, the center of the image 
is shifted from the catheter to the centroid of the lumen, and the image is converted back to the polar 
domain relative to the new image center. Figure 2.2 depicts the OCT and the attenuation images with the 
lumen border, the centroid and the corresponding polar image before and after the origin shift.
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Figure 2.2 |  Top left and right: OCT and attenuation images with lumen border and the centroid. Bottom left and 
right: Polar image before and after the shift of origin. 
In the next step, we make a longitudinal attenuation map of the vessel. This mapping display of OCT 
attenuation depicts tissue optical properties in the entire pullback, sampling a user specified depth 
window from the lumen border, which at different conditions can be compared to quantify any difference. 
Such a map image is shown in Figure 2.3.
Figure 2.3 | Longitudinal attenuation map of a vessel sampled at a depth of 100-200 µm depicting the highly 
attenuating features in the entire pullback.
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The attenuation map is made by taking the mean of 20 pixels from the depth of 100 µm from the lumen 
border (100-200 µm) along each A-line in all the frames across the pullback. The resulting longitudinal 
map has dimensions of frame number (x-axis), rotational angle (y-axis) and color codes the mean 
attenuation coefficient from 0-12 mm-1. Such a map may highlight the lipid plaques and other high 
attenuating features in the entire pullback.
Even though the OCT pullbacks at different conditions are undertaken on the same vessel, it cannot 
be expected to exactly match due to factors such as non-uniform rotation, frame spacing and catheter 
orientation. To undertake quantitative comparison the attenuation map at different conditions should 
ideally be co-registered.
Figure 2.4 | Top: The en-face OCT map of pullbacks performed at UB (A0) and FB (B0) conditions; before 
registration. Bottom: The attenuation maps of the same pullbacks (A and B) where * indicates the control points 
used for registration, leading to (B’), the attenuation map after registration.
The registration procedure involves three steps. There is a first step of circularly shifting the images in the 
angular (y) direction. In the next step, an OCT intensity image map, folded out in the same manner as 
the attenuation data is used to select control points at side branches and other landmarks. A 2nd degree 
polynomial is fitted to the control points to derive a non-rigid transformation, which is then applied to 
the images. Finally, the data sets are cropped to represent the same physical length, as the pullback distal 
end can vary slightly and to avoid the guide catheter. Figure 2.4 shows an example of the unregistered 
OCT and attenuation maps with the control points and registered attenuation map images.
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2.2.4 | Image analysis
In order to establish the presence and possible magnitude of the differences between OCT data at 
different temperatures and fixation conditions, we analyzed the images qualitatively [11], assessing 
image appearance, and quantitatively, quantifying the difference in attenuation coefficient.
A quantitative comparison between the attenuation maps will be dominated by mismatched data if it 
depends on pixel-perfect alignment, even with the elaborate registration applied here. To avoid this 
pitfall, the registered images are processed in overlapping kernels of 60×15 pixels, with a step size of 
15 pixels in the angular direction and 5 pixels in the longitudinal direction. We analyze the median value 
of the attenuation coefficient within this kernel size. Any difference between tissue optical attenuation 
in both conditions can be studied by analyzing a scatter plot of the median attenuation, comparing 
a modified condition to the the one that most accurately approximates in vivo circumstances (37°C, 
unfixed tissue). Differences in attenuation are quantified by finding the ratio of the median value of 
the kernels of other conditions against unfixed body temperature condition. We fit a line through the 
origin, the slope of which yields the root mean square difference. The size of the kernel is determined 
by maximizing R2 of this linear fit. The statistical evaluation of the data is completed by a Bland-Altman 
analysis.
A similar analysis as the one discussed above was performed on the OCT image intensity itself, to assess 
any effect of fixation or temperature on the backscatter coefficient µb, which is implicit in I0 in (1) [15]. 
We studied the mean intensity at a depth of 100-200 µm from the lumen boundary, as shown in Figure 
2.4 (A0 and B0).
2.3 | Results 
2.3.1 | Qualitative assessment
The potential similarities and differences of the parametric OCT images of tissues acquired under the 
different conditions are assessed qualitatively and quantitatively. Figure 2.5 illustrates a qualitative 
comparison of the cross-sectional OCT images before and after fixation matched with histology from 
that site in the vessel. 
The histology shows a prominent streak of macrophages extending from the luminal surface into a 
fibro-lipidic plaque. The macrophage infiltration is evident in the OCT images pre- and post-fixation. 
In support of this observation, the corresponding attenuation images demonstrate a highly attenuating 
region consistent with macrophages [15,29].
Qualitatively, no systematic differences were found between the data acquired before and after fixation, 
neither in the OCT images themselves, nor in the attenuation coefficients. We did observe variations in 
image intensity or attenuation, but these could be attributed to position mismatches in the undersampled 
pullbacks.
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Figure 2.5 | (a) H&E and (c) CD68 stained histology image of a cross section. OCT and attenuation images of the 
cross section before (b) and after (d) fixation. The arrows indicate a streak of macrophages in the intima overlying 
a lipid pool. Additionally, luminal macrophage are evident on CD68 staining (arrowheads) with associated 
attenuation.
Likewise, we did not find any systematic difference between the OCT images of the same cross section 
acquired at different temperature conditions. Figure 2.6 shows the CD68 histology stain of a different 
cross section, compared to the OCT and attenuation images of the cross section in cold, room and 
body temperature conditions. The significant plaque feature in the cross section, the macrophages, are 
distinguishable at all temperature conditions. The attenuation values are comparable for all temperatures.
2.3.2 | Quantitative assessment
The repeatability of OCT is well established but subject to effects including variation in pullback 
starting point, heart motion and more importantly the lumenal position of the catheter. Despite 
the use of our cadaveric heart rig and sequential imaging without removal of guidewire or imaging 
catheter, comparison of the OCT maps demonstrate variability preventing a pixel by pixel comparison. 
Consequently, comparison was limited to the median attenuation values in 60x15 pixel kernels in the 
longitudinal en-face map. The control condition for comparison is unfixed tissue at 37°C, considered to 
most closely match in-vivo conditions.
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Figure 2.6 | a) CD68 stained histology image of a cross section. The arrow indicate the streak of macrophages. 
OCT and attenuation images (in units of mm-1) of the cross section in b) UC, c) UR and d) UB conditions. The 
arrows indicate the streak of macrophages.
When comparing the medians from all other conditions to control, ideally they should have identical 
values. So the reasonable quantities to be checked are the ratio of the median attenuation coefficient in 
matching regions in different conditions, and the slope of the line through the origin of the scatter plot 
of medians (the coefficient of proportionality).
Figures 2.7(a) and 2.7(b) show the attenuation map of fresh body temperature of a vessel with the 
considered kernals of 60×15 pixels and the moving kernel step size. Figure 2.7(c) depicts the scatter plot 
of the median of the kernels between the two conditions with the fitted line through the origin and the 
R2 value.
Figure 2.8 shows the box plot of the ratio of the median attenuation values of all conditions against UB 
condition and the resulting coefficient of proportionality in each case.
Bland-Altman analysis produced mean differences close to zero for all comparisons (ranging from 0 to 
0.2 mm-1) and 95% confidence intervals between 0.5 and 1.5 mm1, which is consistent with the accuracy 
of the attenuation algorithm. No statistically significant trends were found.
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Figure 2.7 | a) Attenuation map of a vessel with the considered kernels b) the part of the map (in a) highlighted in 
green depicting the overlapping kernels c) scatter plot of the medians of the kernels in UB and UR conditions with 
the fitted straight line through origin (red) and the line with slope 1 (black) and the lines with +/- 1 mm-1 (dotted).
Figure 2.8 | (left y-axis) Box plot of the ratio of the median values of OCT intensity and attenuation in 60x15 
kernels, plotted as median (red), 25th and 75th percentile (blue box), and 1.5 times the interquartile (whiskers). 
(right y-axis) Black squares: coefficient of proportionality extracted from the slope of the fit line for all the 
conditions. 
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In an analysis of the OCT image intensities, we found that the scatter in the data is much larger than 
for the attenuation coefficient, with typically R2≈0.4 for the linear fit and a median intensity ratio 
interquartile range of 0.6. One finding which appears to be robust, however, is that the image intensity is 
11% higher in the OCT data of fixed tissue compared to unfixed, as measured by the ratio of the region 
medians as shown in Figure 2.8.
2.4 | Discussion
This study quantifies the effects of common tissue preparation steps on the optical properties of the 
artery wall. As new OCT analysis techniques are routinely developed on ex vivo tissues, it is important 
to know how temperature and tissue fixation affect the parameters that can be quantified from the OCT 
images. We extract the attenuation coefficient from the OCT images, a parameter that is relevant for 
tissue type. In our data, we see very small differences induced by temperature and fixation: relative to 
unfixed tissue at 37°C, the attenuation coefficient differs by a few percent at most in other conditions.
We studied the ratios of median attenuation values in different conditions, and the coefficient of 
proportionality. The ratios are scattered in a narrow range around unity, while the coefficient of 
proportionality, which is more sensitive to outliers, is around 0.95. A 5% deviation converts to 0.5 mm-1 
error on 10 mm-1 attenuation. We typically find that the attenuation of a single tissue type varies within 
a range larger than 0.5 mm-1, so the variation in the condition is not resolvable. This result supports 
the main conclusion of this work: tissue attenuation in coronary arteries ex vivo can be studied in fixed 
tissues, without special precautions for temperature, which may greatly facilitate data collection. The 
image intensity itself does appear to be affected by fixation. In the absence of attenuation changes, this 
suggests that the scattering phase function is modified by the microstructural changes in the tissue, 
leading to a larger backscattering coefficient. This observation is consistent with our experience that 
OCT images in fixed tissues appear brighter than matched unfixed images.
We base our attenuation comparison partially on linear fits through the scatter plots of the median 
attenuation in different conditions. However, the influence of temperature and fixation on the optical 
properties of different tissues need not be the same, which potentially causes a regression to the mean. 
In general, a linear relationship cannot be expected between the maps of different conditions, but we 
did not find any evidence for deviations from simple proportionality. This finding is further supported 
by the absence of trends in the Bland-Altman analysis. We chose to minimize the number of degrees of 
freedom by fitting a line through the origin.
We compare the median, and not the mean, because it is less sensitive to skewed distributions of the 
attenuation values in a region of interest. Other signal or image statistics could be studied as well: 
it is conceivable that changes to the tissue microstructure caused by handling or preservation affect 
the intensity variation or the scattering phase function. Such changes could show up in higher order 
intensity statistics, or the backscatter coefficient, respectively. The latter is proving to be a parameter 
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that is surprisingly resistant to quantitation. As we have demonstrated the relation between attenuation 
and tissue type [15], while other parameters are less studied, we chose to restrict the present study to 
attenuation only.
We have developed an analysis method that is robust against common registration errors. The OCT 
pullback has a large frame pitch relative to the width of the point spread function (the “frame thickness”) 
that can make it difficult to find the same cross section even in pullbacks of the same region of a vessel. 
Each frame of the OCT pullback is effectively made up of a spiral image of 200 µm through the vessel 
and therefore may not be accurately represented by a 3 µm thick histology section. This is essentially a 
sampling problem, that we deal with by constructing a longitudinal representation of the pullback to 
make quantitative comparisons. This has several advantages over analysis in cross section images. A 
longitudinal map brings out tissue features as a whole, along the vessel, while in a cross section only a 
part of it can be located. It also allows for non-rigid registration to correct for non-uniform rotation and 
variations in effective pullback speed (due to cardiac motion in vivo). The longitudinal representation 
remains a two-dimensional cross section through a three-dimensional data set, and sacrifices depth 
resolution. For detailed analyses, several longitudinal maps at different depths from the lumen boundary 
can be extracted. In order to eliminate sensitivity of the comparison to pixel-perfect alignment, we 
studied the median values of kernels of 60×15 pixels. This is necessary to extract meaningful differences, 
as any parametric difference between the various conditions would be obscured by large differences 
introduced by mismatches. The size of the kernel 60×15 pixels was chosen by maximizing the R2 values 
of the fit.
The accuracy of the non-rigid registration step depends on the number of landmarks that are usable 
as control points. We attribute the remaining scatter in the data sets to persisting registration errors. 
These introduce a variance that is not explained by the analysis model and affect the R2 of the fit for the 
medians. We find R2≈0.6, which still represents significant accuracy of the fit.
2.4.1| Study limitations
Co-registration of multiple OCT images acquired at varying conditions, and comparison against histology 
is challenging. Despite careful reproduction of OCT imaging at all conditions and computational co-
registration we concede that exact matching of images is not possible. However, we believe our methods 
of matching generate accurate comparisons. The inherent differences in longitudinal resolution between 
OCT (200um) & histology (3 um) highlight OCT’s tendency to under-sample the vessel. We have 
overcome this by undertaking extensive histological preparation of vessel segments containing plaque of 
interest, allowing ‘best-fit’ matching with the lower resolution OCT images. Maintenance of steady-state 
temperature in the cadaveric heart model required prolonged infusion of PBS, incubated to the selected 
condition temperature. Despite measurement of vessel temperature with a needle-probe thermometer, it 
is possible that a temperature gradient existed from the vessel lumen into deeper tissue but not expected 
to be very significant considering the penetration depth of the OCT. The ultimate aim of this work 
is to facilitate translation into the clinical setting; however, we must concede that despite evaluation 
of variations in attenuation generated by temperature and fixation, other significant differences exist 
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between the ex-vivo & in-vivo environment. Particularly, the influence of cardiac motion on image 
acquisition and the potential influence of luminal blood on image quality.
2.5 | Conclusion
The results show that the ratio of the median attenuation values of kernels and the coefficient of 
proportionality or the slope of the line through the origin fitted for the medians is close to unity for 
every condition against the base condition. The largest deviation in slope from one is 0.06, leading to 
a change in tissue attenuation of less than 1 mm-1, which is the approximate accuracy of the algorithm. 
The results suggest that fixation and room temperature conditions in the ex-vivo OCT experiments do 
not induce a systematic error. 
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Abstract
Objective: Lipid-core atherosclerotic plaques are associated with disease progression, procedural 
complications, and cardiac events. Coronary plaque lipid can be quantified in optical coherence 
tomography (OCT) pullbacks by measurement of lipid arcs and lipid lengths; parameters frequently 
used in clinical research, but labor intensive and subjective to analyze. 
Methods: In this study, we investigated the ability of quantitative attenuation, derived from intravascular 
OCT, to detect plaque lipid. Lipid cores are associated with a high attenuation coefficient. We compared 
the index of plaque attenuation (IPA), a local quantitative measure of attenuation, to the manually 
measured lipid score (arc and length) on OCT images, and to the plaque characterization ex-vivo. 
Results: We confirmed a correlation between the IPA and lipid scores (R2>0.7). Comparison to histology 
shows that high attenuation is associated with fibroatheroma, but also with macrophage presence. 
Conclusions: IPA is a robust, reproducible, and user-independent measure that facilitates quantification 
of coronary lipid, a potential tool in clinical research and in guiding percutaneous coronary intervention.
 
Keywords: Optical coherence tomography, attenuation, lipid core plaque
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3.1 | Introduction
Sudden rupture of a lipid-rich atherosclerotic plaque, causing acute myocardial infarction is one of the 
major causes of death worldwide. Early detection of such coronary plaques may influence treatment 
strategies and facilitate a reduction in clinical events secondary to ischemic heart disease [1]. The 
lipid core plaque (LCP) or fibroatheroma is a type of atherosclerotic lesion prone to develop unstable 
features under the influence of inflammatory processes and mechanical forces. Hence, imaging of 
tissue composition, especially in LCP, plays an important role in recognizing plaque instability [2]. LCP 
detection also has implications in the guidance of coronary interventions, as these plaques have been 
implicated in peri-procedural and follow-up events [3-8]. Intravascular optical coherence tomography 
(OCT) is now widely used as a clinical tool, imaging vessel lumen and wall morphology for guidance of 
stent placement and optimization [9-12]. OCT is a catheter-based imaging technique that provides high-
resolution images of the arterial wall. Interpretation of the images allows for a qualitative assessment of 
the tissue composition [7,11,12].
Measurement of lipid length and lipid arc in OCT for calculation of a lipid score is a common method 
to quantify lipid in cardiovascular research [13,14]. This score is an indicator of the extent and severity 
of atherosclerotic disease in the coronary arteries. It provides patient and lesion-specific diagnostic 
information, and may serve as a metric of plaque progression in temporal studies. Currently a skilled 
OCT reader is required to score lipid accumulations, and it is a time-consuming manual procedure 
with considerable inter-observer variability [13]. An automated tissue score that can provide the same 
information can be a very useful tool in research with potential for clinical utility.
Various tissue components have different optical parameters and this contrast can be exploited to devise 
a tissue characterization method based on IV-OCT data [15]. Quantification of tissue optical parameters 
may assist image interpretation by OCT users. The attenuation coefficient is a robust tissue optical 
parameter [16] that has been proposed for tissue characterization [17-19]. Lipid-rich necrotic core and 
macrophage infiltration have high attenuation compared to fibrous tissue and other plaque components. 
Such methods have recently been augmented with statistical image metrics to achieve tissue detection 
[20].
In this study, we validate optical attenuation imaging of coronary plaque tissue type in an ex-vivo setting, 
using whole heart specimens harvested from cadavers and imaged in a purpose-built setup. We focus 
on the ability of attenuation imaging to identify coronary plaque lipid. The objective of the study was to 
compare the quantitative attenuation scores with the manually measured lipid scores of plaque segments, 
which were characterized based on the histology.
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3.2 | Materials and methods
3.2.1 | Specimens
Whole cadaveric hearts used were obtained from the Bristol Heart Valve Bank and excised within 48 
hours post-mortem and stored at 4°C [21]. A short guide catheter was introduced into the right coronary 
artery to facilitate intravascular imaging and fixed in position with sutures. All tissues were handled 
in accordance with the local ethics regulations. The heart specimen was held within a custom-built 
Perspex container, with adapters on both sides of the lid allowing connection of the guide internally, and 
a Y-connector and pressure/injector manifold externally [21]. For the study a total of 6 heart specimens 
were imaged. 
3.2.2 | IV-OCT imaging
For intravascular OCT imaging, the imaged artery was perfused with phosphate buffered saline (PBS) 
and the intracoronary pressure was maintained at 100 mmHg. The OCT image pullbacks of the coronary 
arteries were performed at 20 mm/s. The OCT system used for imaging was a C7-XR with Dragonfly 
catheter (St. Jude Medical Inc. St. Paul, MN, U.S.A).The end of the guide catheter served as a reference 
point.
3.2.3 | Histology and plaque characterization
The imaged vessels were pressure-fixed while still on the heart with buffered formalin at 100 mmHg for 
15 minutes, excised from the heart, and fixed with buffered formalin for 24 hours. Then the vessels were 
embedded in paraffin and cut into 4-mm blocks with the end of the guide catheter serving as a reference. 
The proximal face of each block was cut at 3 µm thickness for histological analysis and serial sections 
stained with Haematoxylin and Eosin (H&E), Elastic Van Gieson (EVG), Cluster of Differentiation 68 
(CD68) and smooth muscle cell α-Actin stains. CD68 and α-Actin were visualized using mouse anti-
CD68 (DAKO M0814 and M0876 mixed 1/200 of each), and mouse anti-α actin (DAKO, M0851 1/200), 
or matched mouse IgG control, followed by biotinylated goat anti-mouse and extravidin-HRP conjugate 
with DAB staining.
Twenty-three atherosclerotic plaques were identified from the six cadaveric heart specimens. A skilled 
pathologist analyzed the plaque characteristics by the histological staining and classified the plaque type. 
The lesions were classified into pathological intimal thickening, pathological intimal thickening with 
macrophage infiltration and fibroatheroma using standard criteria [2,22]. Fibroatheroma with less than 
65 μm cap thickness was classified as thin-cap fibroatheroma.
3.2.4 | Parametric imaging
The acquired OCT images were analyzed to quantify the attenuation coefficient of the tissues by fitting 
the OCT signal to a single scattering model [18,19].
  ‹Id›=T(r)S(r)I0e-μtr, (1)
503688-L-sub01-bw-Gnanadesigan
3
39Optical coherence tomography attenuation imaging for lipid core detection | 
where S(r) is the OCT signal roll off and T(r) is the point spread function (PSF) of the catheter [23]. 
The attenuation coefficient µt is the parameter of interest. The attenuation calculation and the model 
implementation were done in Matlab release 2012b (The Mathworks, Inc., Natick, MA, USA). The model 
is fitted in the polar image, in every A-line starting from the edge of the lumen [18,20], in small windows 
of varying length [24] to extract the attenuation coefficients. The accuracy of the extracted attenuation 
coefficient is approximately 1 mm-1 [18]. The data analysis results in an attenuation image per frame of 
the pullback. Figure 3.1 depicts a frame of OCT, its corresponding attenuation image and histology.
Figure 3.1 | A representative OCT frame and the corresponding attenuation image depicting high attenuation 
features and the corresponding Histology stains. The arrow heads point to a streak of macrophages that shows 
high attenuation and are clearly stained in CD68. The dashed scale bar equals 1 mm.
We made longitudinal attenuation maps of the vessel depicting the tissue properties of the intima along 
the entire pullback. The map was constructed by sampling the maximum value of attenuation between 
the lumen border and the internal elastic lamina (IEL) as shown in Figure 3.2. The en-face map display 
has dimensions of frame number (horizontal-axis), rotational angle (vertical-axis) and color-codes the 
maximum attenuation coefficient per A-line in the range 0-12 mm-1. Such a map highlights strongly 
attenuating features like the lipid plaques in the entire pullback [16] and corresponds well with a visual 
assessment of LCP in the OCT data by an expert reader [25]. 
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We also defined an Index of Plaque Attenuation (IPA) to quantify the parametric image. IPA is the ratio 
of the number of pixels in the attenuation map or a segment of it with an attenuation coefficient greater 
than a certain threshold x to the total number of pixels, multiplied by a factor of 1000. Mathematically 
it is represented as 
  IPAx=          X1000N(μt≥x)Ntotal  (2)
where N is the number of pixels. x is the threshold in attenuation coefficient, with a maximum value of 
12 mm-1, that enables IPA to represent a particular tissue type. 
The IPA was calculated in 4mm windows, covering a plaque segment. For the frame pitch of 200 µm 
that we used in our study, a window for IPA computation comprises 20 OCT frames. The OCT data 
were matched to the histology cross-sections based on longitudinal position and general anatomy (side 
branches and presence of plaque). 
Figure 3.2 | A representative image of the en-face map depicting the attenuation features across the vessel and the 
4 mm segment of a plaque that would be used to calculate the IPA. The inset plot shows the IPA for the segment 
for different thresholds ‘x’ in IPAx. Color scale runs from 0-12 mm-1. 
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3.2.5 | Lipid measurements
Lipid measurements were made on the OCT frames, using the Ilumien offline OCT review workstation 
by St. Jude Medical (St. Paul, MN, USA). The lipid length was measured by detection of sequential OCT 
frames within a plaque segment containing lipid, defined as a diffusely bordered signal-poor region with 
high attenuation by the signal rich region covering them [7,26]. The pitch of the OCT enabled calculation 
of the lipid length in mm. The lipid arc measurements were made by defining the circumferential extent 
of the lipid core from the vessel centre and a mean for the plaque segment was calculated. Combining 
both measurements a lipid score was calculated, which is the product of the average lipid arc of the 
segment and the lipid length of the segment. To establish the relation between OCT lipid score and 
optical attenuation coefficient, we computed the correlation (Pearson’s r) between lipid score and IPAx 
for different values of x (1,1.5,..12) in all segments.
3.2.6 | Statistical analysis
Continuous variables are expressed as mean (standard deviation), or median (interquartile range; IQR) 
and categorical variables are expressed as percentages. The regression analysis was performed on the 
lipid measurements and IPA, with linear least squares fit and the coefficient of determination r2 (square 
of the correlation coefficient r) was used.
3.3 | Results
According to the analysis of the histological sections, there were 16 fibroatheromas, 3 fibrous plaques, 
2 pathological intimal thickenings and 2 pathological intimal thickenings with macrophage infiltration. 
One fibroatheroma with less than 65 microns cap thickness was classified as thin cap fibroatheroma.
We measured the lipid scores in the OCT recordings of the segments of interest. The median of the mean 
lipid arc of the plaques was 81.98±45 degrees and the median of the lipid length was 3.9±2.1 mm. The 
scores ranged from 0 to 638.4 mm°. There were eight plaques that did not have the characteristics of LCP 
according to the consensus OCT criteria [7].
The maximum correlation coefficient between the lipid score and IPAx was found for a threshold of 
x=8.5 mm-1 (IPA8.5), and equaled r=0.85 (p<0.0001). The relationship between IPA and the lipid scores 
for all the 23 plaques are given in Figure 3.3. The data points in the graph are color-coded based on the 
plaque type classification as shown in the legend.
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Figure 3.3 | Correlation between IPA8.5 and Lipid score by OCT (mean lipid arc*lipid length). The inset plot 
shows the correlation coefficient with the lipid score for different thresholds ‘x’ in IPAx. The legend shows the 
color code for plaque types.
3.4 | Discussion
This study investigated the ability of the index of plaque attenuation (IPA), a bias free and reproducible 
summary measurement of attenuating tissue types, to detect lipids. The study aimed to validate OCT 
attenuation coefficient as a lipid-core detection tool. The main finding of the study was that the OCT-
derived index, the IPA8.5, have a significant correlation (R2>0.7) with the manual lipid score in OCT 
images, which enables automation of the coronary plaque lipid assessment by OCT. Lipid scoring is a 
time consuming process, where frame-by-frame analysis and measurement is required. Previous studies 
which compared the lipid score by OCT to automated indices like the near-infrared spectroscopy 
(NIRS)-based Lipid Core Burden Index (LCBI) found a lesser correlation (R2=0.436) [27]. This 
weaker association between OCT measurements and LCBI may be explained by registration errors in 
measurements made by different catheters, but also by the physically different detection mechanisms 
(scattering-dominated attenuation for OCT, vs. optical absorption in NIRS). The IPA, which is the result 
of automatic computation of plaque attenuation, has the potential as a clinical tool as it can indicate 
the presence and location of lipid rich plaques in an entire pullback, and provides an alternative to 
manual scoring in cardiovascular research. IPA could be displayed as a color-coded block along the 
vessel indicating probable lipid core plaques as shown in Figure 3.4. IPA, being an index calculated from 
a physical parameter, is robust and reproducible.
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Figure 3.4 | Color coded IPA8.5 as bar embedded in a OCT L-mode image of an artery. 
The Figure 3.3 demonstrated that thick cap fibroatheroma exhibited a range of low to high IPA values, 
showing that lipid content is just one tissue component contributing to optical attenuation. We only 
found one thin cap fibroatheroma in our data, which had large OCT-lipid burden as expected [28]. It 
had a high IPA value, illustrating the relation between manual OCT measurements and automatic IPA 
analysis. Its typical dense macrophage infiltration by histology contributed to the observed attenuation. 
Among the four plaques classified as pathological intimal thickening (PIT), two had macrophage 
infiltration. The two PITs with macrophage exhibited high IPA values even though pathological evidence 
of lipid was not available. The gap between the PITs with and without macrophages was very significant, 
as expected. The three fibrotic plaques had near zero IPA values, as expected. The three fibrous plaques 
and the four PITs were among the eight plaques scored as having no lipid on OCT, along with one 
fibroatheroma with deep extra-cellular cholesterol.
3.4.1 | Limitations
Our data set is targeted towards validation of lipid measurements, and so does not reflect the heterogeneity 
of atherosclerosis in a clinical setting, with few plaques other than FA, and only one TCFA. The two 
included macrophage-infiltrated PIT plaques exhibit high attenuation even in the absence of histological 
evidence for lipids, a known mechanism resulting in false positives for lipid detection by OCT [7,29,30]. 
It was not possible to compare IPA with the lipid scores from histology as it is not practical to measure 
lipid length and the mean lipid arc in the whole segment. The attenuation calculation itself is automated 
and fast but in calculation of IPA, manual media segmentation is currently necessary to avoid artifacts 
due to the intima-media border. To be able to automate the whole process and for application to large 
datasets, automated media segmentation is required. This software is currently under development in 
our institute [31]. 
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3.5 | Conclusion
We validated the optical attenuation as a tissue classification tool. We investigated a quantitative 
measure of the attenuating tissue types, the IPA. Our results show that the OCT-derived index of plaque 
attenuation has a correlation (R2>0.7) with the conventional lipid score on OCT images. The results 
highlight the potential of a robust and fast identification tool of lipids in OCT pullbacks. 
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Abstract
To investigate the ability of atherosclerotic tissue characterization in vivo, we are conducting the OC3T 
study: a prospective single-center validation study of 61 patients, comparing OCT-derived optical 
attenuation to NIRS/IVUS. We compare the chemogram and the en-face OCT attenuation map. The 
plaque area with the highest 4mm Lipid Core Burden Index (LCBI) was compared with the OCT Index 
of Plaque Attenuation (IPA) for the same. Unlike LCBI, IPA is significantly larger in thin-cap than in 
thick-cap plaques.
Keywords: Optical coherence tomography, attenuation, lipid core plaque
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4.1 | Introduction
Diagnosis and effective intervention on ischemic heart disease benefits from early detection of coronary 
plaques that are likely to precipitate clinical events [1]. Plaque morphological features that have been 
associated with instability include a lipid-rich necrotic core, contained by a fragile layer of fibrous tissue 
that can be compromised by inflammation and mechanical forces [2]. Forces exerted by the variable 
blood pressure, or by intravascular devices used in percutaneous coronary interventions (PCI) may cause 
rupture of the fibrous cap, releasing the thrombogenic material, and leading to acute coronary syndrome 
or periprocedural myocardial infarction (MI). Hence tissue composition is important in recognizing 
plaque instability [3]. Detection of lipid-core plaques (LCP) has important implications for guidance of 
coronary interventions, as LCP has been recognized as a potential factor in periprocedural and future 
adverse events [4-9]. Intravascular optical coherence tomography (OCT) is gaining popularity as a clinical 
tool for assessment of stent placement and optimization [10-14]. OCT provides high resolution arterial 
images, from which vessel wall composition can be assessed by qualitative interpretation [11,15,16]. The 
quantification of tissue optical properties derived from the OCT images has been proposed as method 
to automate tissue characterization, or at least support image interpretation. The attenuation coefficient 
is a robust tissue optical parameter that can be used in tissue characterization [17,18]. Both necrotic core 
and macrophage infiltration, plaque features that have been associated with impaired stability, have high 
attenuation compared to fibrous and calcified tissues [19]. Such analyses have recently been augmented 
with statistical image metrics to achieve tissue identification [20].
A catheter based intracoronary near-infrared reflection spectroscopy (NIRS) and intravascular 
ultrasound (IVUS) system (InfraRedx, Burlington, MA, USA) has been used for lipid detection in vivo 
[21,22], operating by spectrally analysing the reflected light by the tissue. Spectral features are translated 
into a probability for the presence of LCP in the wall of the artery under investigation. The system 
does not, however, provide information on the depth of the lipid core relative to the lumen. This is 
effectively a measurement of cap thickness, which is one of the important factors for determining plaque 
stability. Casuistry suggests [23] that overall features (lipid by NIRS, high attenuation by OCT) coincide 
in images of diseased coronary arteries in patients. We have previously demonstrated the potential 
of optical attenuation coefficient by OCT as a tissue characterization method in ex vivo studies [19]. 
To investigate the ability of atherosclerotic tissue characterization in vivo, we conducted the Optical 
Coherence Tomography Tissue Type (OC3T) study. In this study, we performed a thorough clinical 
validation by quantitative evaluation of the attenuation characteristics of LCP as identified by NIRS-
IVUS. Specifically, we aimed to investigate the potential of OCT attenuation imaging for differentiation 
of the superficial and deep lipids, distinguishing thin and thick cap fibroatheromas.
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4.2 | Methods
4.2.1 | OC3T study
The Optical Coherence Tomography Tissue Type (OC3T) study was a prospective single-centre study, 
performed in Thoraxcenter, ErasmusMC, Rotterdam, the Netherlands, enrolling 85 patients undergoing 
PCI for stable/unstable angina pectoris or acute MI. The study was carried out in accordance with the 
declarations of Helsinki and was approved by the local ethical review committee. Patients with at least 
one coronary lesion requiring PCI were included in the study after having provided written informed 
consent. At least 20 mm of native artery wall accessible to OCT and NIRS-IVUS imaging was required. 
Patients unable to provide informed written consent, under 18 years of age, with haemodynamic 
instability, cardiogenic shock and TIMI 0 flow at target lesion were excluded.
OCT and Lipiscan/IVUS pullbacks were performed in a non-culprit native vessel segment.. The 
imaging region was defined based on angiographic landmarks, such as side-branch take-offs, with a 
recommended length of >2 cm. Both OCT and NIRS-IVUS were performed in the vessel.
The primary endpoint of the study was a quantification of the relation between OCT attenuation and 
plaque type, by OCT analysis and by correlation with NIRS.
4.2.2 | NIRS-IVUS 
The NIRS-IVUS images were acquired using a hybrid optical/ultrasound catheter (TVC, InfraRedx) 
[24,25], in compliance with its instructions for use. An automated pullback (0.5 mm/sec and 16 frames 
per second (fps)) acquired co-registered images of measured probability of LCP presence (PLCP) by NIRS, 
displayed as a color-coded ring (yellow is high probability, red is low), and gray-scale IVUS (Figure 4.1A). 
A so-called “chemogram” displays the lipid probability as a fold-out map of the artery with coordinates 
of longitudinal and circumferential position (Figure 4.1D). This chemogram is co-registered online with 
IVUS data providing structural information and geographic orientation inside the coronary artery Lipid 
Core Burden Index (LCBI) is a quantitative measure calculated from the chemogram that represents the 
fraction of pixels with PLCP>0.6, coloured orange to yellow, in the chemogram, multiplied by a factor of 
1000 [7]. The LCBI is a summary measure of the amount of lipid core plaque along the entire length on 
a 0-1000 scale [26]. In addition to the overall LCBI, the LCBI4mm has been introduced [7,8,27], which 
provides a metric to quantify LCP in 4 mm segments.
4.2.3 | OCT imaging and image analysis
The OCT images were obtained with C7-XR/Illumien and Dragonfly catheter (St. Jude Medical Inc., 
St. Paul, MN, USA). Automated OCT pullback (pullback speed 20 mm/s) was performed during 
simultaneous iso-osmolar X-ray contrast medium (Visipaque 320, GE Healthcare, Buckinghamshire, 
U.K) delivery through the guide catheter, using a power injector (Medrad ProVis, Bayer HealthCare 
LLC, NJ, U.S.A; typical flush rate 3.0 ml/s).
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The resulting OCT images were then analyzed, to quantify the attenuation coefficient of the tissues, 
derived from the OCT signal by fitting a single scattering model [19]:
  ‹Id›=T(r)S(r)I0e-μtr (1)
where T(r) and S(r) quantify catheter optics [28] and OCT system dependent changes in the signal 
with depth in the image, and the parameter of interest is μt, the attenuation coefficient. The attenuation 
calculation and the image analysis were done in Matlab R2012b (The Mathworks, Inc., Natick, MA, 
USA). The model is fitted in the polar image, in every A-line starting from the edge of the lumen [19,20]. 
The accuracy of the extracted μt is approximately 1 mm−1 [19]. The data analysis results in an attenuation 
image per cross-section of the pullback (Figure 4.1B).
To facilitate the comparison with NIRS-IVUS, we made a longitudinal map of the attenuation data 
similar to the chemogram. This display depicts tissue optical properties in the entire pullback, sampling 
a user specified depth window for the maximum value of attenuation from the lumen border to the 
media as shown in Figure 4.1D. Such a map highlights lipid plaques and other strongly attenuating 
features in the entire pullback [29] and corresponds well with a visual assessment of LCP in the OCT 
data by an expert reader [30].
Analogous to the LCBI, we defined the Index of Plaque Attenuation (IPA). IPA is the fraction of pixels 
in the attenuation map with an attenuation coefficient greater than a certain threshold x, multiplied by a 
factor of 1000. The calculation of IPA can be represented as a mathematical formula as follows,
  IPAx=          X1000N(μt≥x)Ntotal  (2)
where the numerator includes pixels with attenuation greater than certain threshold x.
4.2.4 | Image registration and selection of region of interest
Co-registration of the OCT- and NIRS-IVUS-derived data was achieved by ‘folding out’ the OCT and 
IVUS pullbacks, as depicted in Figure 4.1C. The largest side-branch within the imaged vessel segment 
was used as a landmark for longitudinal and angular registration. Subsequently, the maps were cropped 
to represent the same physical length (Figure 4.1C).
The regions of interest (ROIs) were selected from pullbacks with presence of lipid i.e. LCBI>0. The ROIs 
for analysis were selected as 4-mm sections with LCBI4mm>150 in all data sets, computed with a sliding 
window in the chemogram. The threshold ensures presence of lipid in the majority of segments, but 
does allow small plaques to be analysed. If all LCBI4mm<150 in a pullback, the section with the highest 
LCBI4mm was selected. In all OCT pullbacks, we selected the 4-mm (20 frames) sections corresponding to 
the ROIs defined in the NIRS-IVUS data for analysis of the attenuation coefficient. In these OCT ROIs, 
we manually traced the contour separating the bright intima and dark media to minimize attenuation 
artefacts associated with the intima-media border, using the proprietary St. Jude Medical analysis 
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software. The media contour was used as the end of the sampling window per A-line for analysis of the 
maximum attenuation coefficient. If the media was not visible in a region of an image, the contour in 
that sector was interpolated [31]. The matched data sets in the chemogram and attenuation images are 
depicted in Figure 4.1D.
Figure 4.1 | Image acquisition, registration, and display A) Cross-sectional NIRS-IVUS image B) Cross-sectional 
image of OCT and the corresponding attenuation image (color; blue-red-yellow representing 0-12 mm-1) overlaid 
on the OCT image (grayscale) C) IVUS and OCT fold out map of a vessel with the largest side branch marked 
in green asterisk and the cropped region of same physical length represented by red lines D) Chemogram 
representing the probability of lipid in a coronary artery segment; white dotted lines indicate high LCBI 4-mm 
block in this pullback; Attenuation map of the same segment depicting the maximum attenuation coefficients in 
the entire vessel; white dotted lines indicate corresponding selected section. dist- distal, prox-proximal E) Typical 
A-line of a fibrotic (left) and lipid plaque (right) and the fit from the signal model (yellow line).
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4.2.5 | Plaque characterization and cap measurement 
Two independent skilled readers (AK and NSvD) analyzed the plaque characteristics by OCT in all 
ROIs, after reviewing all 20 frames of the selected region. They classified plaque type and, if appropriate, 
performed a cap thickness measurement. The lesions were classified into fibrous, fibrocalcific (FC) and 
fibroatheroma (FA) using standard criteria [11]. Mixed plaques were classified as fibroatheromas. In 
fibroatheromas the thinnest point of the cap in the plaque was selected in the set of 20 frames and 
measured. Differences in cap thickness and plaque type characterization, resulting from the freedom 
to choose the frame containing the thinnest cap [32], were resolved by consensus between the two 
observers. Aided by the cap thickness measurements, fibroatheroma was classified into thin-cap and 
thick-cap fibroatheromas. Fibroatheroma with less than 65 µm cap thickness was classified as thin-cap 
fibroatheroma (TCFA) [3]. 
4.2.6 | Statistical analysis
Continuous variables are presented as mean±SD, or median (interquartile range; IQR), and nominal 
variables as n, (%). Two-sided significance level of p-value was used. We investigated the ability of LCBI 
and IPAx to distinguish between TCFA and FA by receiver-operator curve (ROC) analysis, using the 
experts’ classification as the gold standard. LCBI has not been validated for cap thickness evaluation; 
however, it is the only measurement available to the NIRS user and hence it is interesting to know if 
a high LCBI is associated with high-risk plaque characteristics such as cap thickness. To establish the 
relation between lipid detected by NIRS and optical attenuation coefficient, we computed the correlation 
(Pearson’s r) between LCBI and IPAx for different values of x in all ROIs.
4.3 | Results
4.3.1 | Study population and plaque characterization
A total of 85 patients who underwent both OCT and NIRS-IVUS imaging were included in the study 
between July 2012 and July 2013. The automated image analysis stringently requires all images in the 
segment of interest to be free of common image artefacts (e.g. blood in the OCT images), and demands 
a high accuracy in co-registration of OCT and NIRS-IVUS pullbacks. After the application of these 
criteria, 61 pullback data sets remained suitable available for analysis. From the 61 patients’ data, 
the selection criteria resulted in 98 regions of 4 mm that forms the dataset for analysis. The baseline 
characteristics of the analyzed patients are as shown in Table 4.1. 
503688-L-sub01-bw-Gnanadesigan
54 | Chapter 4
Table 4.1 | Baseline Characteristics
N
Age, years
Male
Target vessel
  Left anterior descending artery
  Left circumflex artery
  Right coronary artery
Medical history
  Hypertension
  Dyslipidemia
  Diabetes
  Smoking
  Cardiac family history
  Previous MI
  Previous PCI
  Previous CABG
61
61.9±10
48 (79)
24 (40)
13 (20)
24 (40)
33 (54)
29 (48)
11 (18)
27 (44)
30 (49)
18 (30)
22 (36)
1 (1)
Patient characteristics of analyzable data. Values are mean±SD or n (%). Abbreviations: CABG, coronary artery bypass graft; MI, 
myocardial infarction; PCI, percutaneous coronary intervention.
The two OCT experts reached a consensus classification for all 98 segments of interest, presented in 
Table 4.2. The cap thickness measurements in the FA and TCFA categories and the LCBI and IPA values 
for all the categories are also listed.
Table 4.2 | Consensus Plaque type classification
Fibrocalcific Fibrous Fibroatheroma TCFA
No. 5 8 70 15
Cap thickness (microns) NA NA 150±62 54±8
LCBI 285±93 151±106 260±145 330±153
IPA 115±54 22±28 70±45 140±68
Plaque characterization. Cap thickness, LCBI and IPA values are mean±SD. 
4.3.2 | Detection of lipid-core plaque and thin cap fibroatheroma
The maximum correlation coefficient between LCBI4mm and IPA was found for a threshold of x=6 mm-1, 
and equaled r=0.4, (see Supplementary Figure 4.1).
Using the readers’ characterization as classifier, ROC curves were made for IPA values with different 
attenuation thresholds x as well as for LCBI. IPA with threshold 11 mm−1 (denoted IPA11) has the greatest 
area under the curve (AUC), making it the strongest differentiator between FA and TCFA. Figure 4.2 
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shows the ROC curves for LCBI and IPA11. The best cut-off value of IPA11 is 110, which minimize the 
distance between the curve and the upper corner of the ROC curve [33], for the differentiation.
Figure 4.2 | ROC curves for FA and TCFA differentiation. OC curves of LCBI4mm and IPA11 for the ability to 
differentiate FA and TCFA with the OCT readers classification as ground truth. The AUC values indicate that 
IPA11 has the maximum ability to differentiate FA and TCFA. The inset plot shows the area under the curves for 
different thresholds ‘x’ in IPAx. Abbreviations: FA, Fibroatheroma; TCFA, Thin cap fibroatheroma; LCBI, Lipid 
core burden index; IPA, Index of Plaque attenuation; AUC, Area under the curve.
IPA11 was significantly higher in TCFA compared to FA (p<0.0001; Figure 4.3). Although the LCBI 
was also higher in TCFA compared to FA, this difference did not reach significance (p=0.097) for 
discrimination between thick and thin cap LCP. Table 4.2 shows the mean values with standard deviation 
for these variables.
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Figure 4.3 | Boxplot of LCBI and IPA values in thin cap and thick cap fibroatheromas. Median LCBI4mm was 242 
(interquartile range: 161-342) for FA, for TCFA 302 (IQR187-442) (p=0.10). Median IPA11 for FA was 60 (37-103) 
which was significantly lower than in TCFA (median 141 (98-159); p<0.001). IPA11 can significantly differentiate 
(p<0.0001) whereas the differentiation based on LCBI4mm is not significant (p>0.05). Abbreviations: FA, 
Fibroatheroma; TCFA, Thin cap fibroatheroma; LCBI, Lipid core burden index; IPA, Index of Plaque attenuation.
4.4 | Discussion
This study introduces the index of plaque attenuation (IPA), a bias-free and reproducible summary 
measurement of attenuating structures in the coronary vessels. Highly attenuating features have 
been linked to histopathological markers of plaque vulnerability. This study aimed to validate optical 
attenuation as a plaque characterization tool in vivo. The main finding of our study was that an OCT-
derived marker of plaque attenuation, the fraction of image pixels with optical attenuation greater than 
11 mm-1 (IPA11), can reliably differentiate between thin and thick cap fibroatheroma. It is superior 
compared to LCBI for making this distinction. Deeper lipids exhibit reduced attenuation in OCT 
images, which enables the discrimination of TCFA and FA by IPA11. The correlation between IPA and 
LCBI is modest, a finding that indicates a limited specificity of optical attenuation to detect lipid overall 
(see supplementary discussion). Fibrocalcific plaques in the data set also exhibit elevated IPA11, albeit 
significantly (p=0.02) lower than TCFA. The contrast between FC and TCFA is similar for LCBI and 
IPA11, so the FC plaques apparently also contain lipid. Previously published data on attenuation of purely 
(non-lipidic) calcified plaques shows these have low attenuation [20,23]. 
The ability of NIRS-IVUS to detect the lipid core plaques that may cause peri-procedural MI [7] and 
STEMI [34] has been shown before with the use of the maximum 4-mm LCBI to detect lipid core 
plaques, demonstrating how intravascular imaging can be a powerful tool to identify the lipid core 
plaques that may be unstable [35]. Similarly, qualitative OCT assessment of plaque morphology offers 
potential to influence clinical decision making during PCI and risk assessment [36,37], as observed 
with NIRS [7]. Automatic computation of OCT plaque attenuation could potentially be integrated in 
future clinical practice because it can highlight the presence of TCFA in a complete pullback, without 
the need for a time-consuming frame-by-frame inspection and manual measurements in the pullback 
503688-L-sub01-bw-Gnanadesigan
4
57Automated characterization of lipid-core plaques in-vivo by quantitative OCT tissue type imaging | 
data. OCT-derived IPA11 may be a feasible method to detect LCP with a thin cap, an important indicator 
for plaque instability [3]. In a clinical application, realistic implementation would include automatic 
media segmentation as discussed above, after which the attenuation analysis can be overlaid on the OCT 
images. The carpet display (see Figure 4.1B) and colour coded IPA11 displayed on the longitudinal section 
(similar to the block chemogram used in NIRS), would enable direct overall assessment of plaque in the 
artery to guide revascularization procedures. The utility of such a tool would need to be evaluated in a 
dedicated study enrolling a larger group of patients. Application to large data sets will be facilitated by 
automated media segmentation, a tool that is currently being developed in our institute [38]. Our study 
results reiterate that 4-mm LCBI was not designed to quantify cap thickness, and indeed cannot reliably 
differentiate the thin and thick cap fibroatheroma. 
4.4.1 | Limitations
This study has several limitations. The selection of plaques was based on the lipid positive regions 
identified with LCBI calculated from NIRS data. This means that the optical attenuation of non-lipid 
plaque was not included. Highly attenuating features that are not associated with LCP, such as superficial 
macrophage foam cells [39], would reduce the specificity of OCT-based plaque detection. This is true 
also for qualitative OCT plaque characterization, and is recognized as one of the major pitfalls in OCT 
image interpretation [11,40]. Such attenuating features that are not associated with LCP also lead to the 
modest correlation between LCBI and IPA overall (see Supplementary Discussion).
The spatial resolution and data complexity is quite different for NIRS and OCT. While by a strict 
definition NIRS is not an imaging technology with a well-defined resolution, it is clear that the averaging 
kernel with which the data is being acquired is much larger for NIRS than for OCT. Also, NIRS provides 
a single spectroscopic measurement per A-line. We reduced the information content of the OCT data 
to accommodate the validation of OCT attenuation by NIRS data. This simplification consisted of the 
reduction of the OCT measurements to a single value per A-line, and an area measurement of high 
attenuation per 4 mm segment. This procedure undoubtedly loses image features that could be helpful in 
tissue characterization. Further exploratory studies on clinical data [38] and more extensive comparisons 
of OCT signal analysis with histology are ongoing to address these limitations.
The pullback images, especially IVUS, suffer from longitudinal motion artefacts that result in imperfect 
co-registration [41]. Inclusion of multiple fiducial points may remedy this problem, but as landmarks are 
often visible multiple times in an IVUS pullback, this is a delicate procedure. Since we process the data in 
4-mm blocks (larger than the anticipated mismatch), and do not require accurate circumferential image 
matching, the final effect on our quantitative data is limited.
503688-L-sub01-bw-Gnanadesigan
58 | Chapter 4
4.5 | Conclusion
We validated OCT-derived optical attenuation as a tissue characterization tool. We expressed plaque 
attenuation in a local measure of highly attenuating tissue, the index of plaque attenuation (IPAx), 
where x is the threshold for high attenuation in mm-1. IPA11 can differentiate TCFA and FA with high 
sensitivity and specificity. This analysis might allow a fast and accurate TCFA detection in pullback data 
sets without requiring inspection of every individual frame.
4.6 | Perspectives
Competency in Patient Care and Procedural Skills: This newly introduced index of tissue optical 
attenuation enables a fast and reproducible interpretation of plaque morphology in everyday clinical 
application of OCT.
Translational Outlook: Automated analysis of complete OCT pullbacks, which can indicate thin cap lipid 
core plaques, can provide guidance in PCI.
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4S.1 | Supplementary discussion
4S.1.1 | Relation between NIRS lipid and optical attenuation
Upon computation of the correlation between IPA and LCBI, we found the maximum r for x = 6 mm−1 
in IPA calculation. The correlation between the IPA6 and LCBI was modest (r=0.4) as shown in Figure 
4S.1. Of the 98 plaques, 15 plaques had also calcification by OCT which could be one of the influencing 
factors.
Supplementary Figure 4S.1 | Correlation of LCBI4mm withIPA6. Correlation between the LCBI4mm and IPA with 
threshold 6 mm-1. Abbreviations: LCBI, Lipid core burden index; IPA, Index of plaque attenuation.
A straightforward explanation for the modest correlation of OCT-derived optical attenuation coefficient 
with probability of LCP by NIRS may be the fact that there are more attenuating tissues than lipid-rich 
necrotic core alone, macrophages chiefly among them. We also observed that a thick layer of overlaying 
tissue tends to reduce the attenuation coefficient, likely as a result of multiple scattering processes [42]. 
The LCBI is by nature less prone to this effect of overlaying tissue layers. The reduced attenuation of 
deeper lipid supports the second finding of this study: a significant difference between thin and thick 
cap fibroatheroma by OCT-based IPA11. This moderate overall agreement in detection of lipids between 
OCT and NIRS has also been demonstrated by a previous study, performed with non-automated analysis 
of plaque morphology by OCT [43]. In our study, we utilised the OCT attenuation coefficient, an optical 
parameter which can be automatically computed from the data, and as such does not suffer from user 
variability. The comparison between LCBI and IPA is further facilitated by the fact that both are relative 
area measurements, which the OCT-based product of lipid arc and lipid length is not. LCBI and IPA do 
not necessarily measure the same tissue property, as is evident from the correlation coefficient.
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Discrepancies in the correlation of IPA with LCBI were found both for plaques with low, as well as 
with high IPA. High IPA (large area with attenuation above the threshold value) with low LCBI may be 
attributed to attenuation by the foam cells or macrophages which may cover a larger area than the LCP 
itself, thus giving a false positive diagnosis of lipid presence by OCT. The prominence of macrophage 
attenuation is related to their often superficial occurrence, even in early lesions. Macrophages are a 
common confounder in OCT image interpretation [44] and the main source of false positives in LCP 
detection by attenuation imaging. Similarly, fibroatheromas with a calcified core might be misidentified 
by NIRS, giving a false negative diagnosis for LCP [45], while appearing as highly attenuating structures 
on OCT. Conversely, deep or small lipid pools are a leading cause of false-positive LCP by NIRS [45] 
but may still have low OCT attenuation. Likewise, mixed plaques with calcification may have less signal 
attenuation than the non-calcified necrotic cores, resulting in lower IPA, which could be a source of 
false-negatives, reducing the area under the curve in the ROC analysis. NIRS suffers from the same 
limitation but not necessarily equally strongly (Table 4S.1).
Supplementary Table 4S.1 | Thin cap fibroatheroma detection.
NIRS OCT
False Positive Deep lipid pools Superficial Macrophages
False Negative Fibroatheromas with calcification Fibroatheromas with calcification
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Abstract
Optical coherence tomography is a widely used morphological tool that provides high-resolution images 
of the arterial wall. The OCT images allow tissue characterization of the atherosclerotic plaques by the 
various analysis methods. Several methods have recently been developed to provide fast and robust tissue 
characterization of OCT. In this study, we qualitatively compare some of these methods by analyzing a 
set of ex-vivo data. The presented methods are valuable in understanding of the atherosclerosis process.
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5.1 | Introduction
Coronary artery disease (CAD) is the major clinical manifestation of atherosclerosis, a focal thickening 
of intima that leads to formation of asymmetric complex lesions as the disease progresses. CAD is one of 
the major causes of death worldwide [1]. The tissue composition of the atherosclerotic plaque can play 
an important role in the prediction of its instability [2]. The detection of tissue types like a lipid core 
has implications in coronary intervention. Lipid core plaques have been implicated in peri-procedural 
and follow-up events [3-7]. Coronary angiography only provides visualization of the arterial lumen, 
but not of the vessel wall, needed to assess atherosclerotic plaque progression [8,9]. Intravascular 
imaging techniques overcome the inherent limitations, like the resolution and the arterial view, of x-ray 
angiographic imaging. 
Intravascular optical coherence tomography is a popular clinical tool for stent placement and 
optimization by imaging the lumen and wall morphology [10-13]. OCT is a high resolution catheter 
based imaging modality that not only provides assessment of luminal measurements and morphology but 
also allows qualitative assessment of tissue composition of the plaque [6,12,13]. The tissue components 
of atherosclerotic plaque have different morphology, appearance and optical parameters, and this allows 
for the development of tissue characterization methods based on IV-OCT images. Automated plaque 
characterization methods may assist image interpretation by OCT users. Since the introduction of IV-
OCT to clinical imaging in interventional cardiology, several methodologies have been developed to 
perform robust and automated analysis for tissue characterization. 
The different atherosclerotic tissue types that are of interest and can be potentially be discriminated 
by OCT are: lipid core present in fibroatheroma and mixed plaque; calcified tissue; fibrotic tissue; 
and regions of inflammation appearing superficially or inside lipid core plaque. Inflamed tissue is 
characterized by dense infiltration with macrophages.
Tearney et al. [14] proposed a quantification of macrophage content by calculating the standard deviation 
of the OCT intensity, a measure of the variability of the OCT signal in a sample area of the image. The 
method quantifies macrophage proliferation in fibrous cap within a selected region of interest (ROI). 
The authors calculated normalized standard deviation (NSD) for 26 lipid rich plaques, and compared 
it to measurements of macrophage positive area in an appropriate histology staining. There was a high 
degree of correlation between OCT and histological measurements of fibrous cap macrophage density. 
The authors proposed that the high NSD is due to the difference in refractive index of the macrophages 
and their surrounding fibrous tissue.
The presence of cells with strong optical scattering generates the variability measured by NSD, which can 
also be automatically quantified as “bright spots”. Phipps et al. [15] used this hypothesis and proposed 
that the bright spots can also occur in the interfaces between plaque components where there are sharp 
differences in refractive indices. Their algorithm detects bright spots in the entire depth of the artery 
based on distance from catheter, SNR of the OCT and tissue depth. They analyzed 1599 OCT images 
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from 14 vessels and compared with histology. Their results suggest that macrophages alone where 
responsible only for 23% of the bright spot regions, while the other etiologies for the bright spots were 
cellular fibrous tissue, interfaces between calcium and fibrous tissue, calcium and lipids, and fibrous cap 
and lipid pool. 
The attenuation coefficient is a robust tissue optical parameter [16] that has been proposed for tissue 
characterization [17-19]. The plaque characterization by Van Soest et al. uses the attenuation coefficient 
calculated by fitting the OCT data to a signal model. The results show lipid-rich necrotic core and 
macrophage infiltration have high attenuation compared to fibrous tissue and other plaque components. 
The method is a fully automated analysis on a speckle reduced A-line of OCT from lumen border 
resulting in an attenuation image, which is color-coded for guidance.
Image texture can also be related to tissue composition, by extracting statistical metrics from local 
regions in the image and creating classifiers by matching with histological interpretation. Athanasiou 
et al. [20] proposed a fully automated method that relies on the processing of the OCT images from 
lumen border to 1.5 mm. They use a K-means algorithm to segment atherosclerotic tissue and calcium, 
supplemented with a classification algorithm to categorize the atherosclerotic tissue into lipid, fibrous, 
and mixed tissue. 
The aim of this study is to present the different methods for tissue characterization in IV-OCT and 
perform a qualitative comparison of their ability to identify the different plaque tissues by running the 
respective analyses on a common data set of ex-vivo images. We then classified the plaque type and the 
various tissue components therein by interpretation of the histology, using series of histochemical and 
immunohistochemical stains.
5.2 | Materials and methods
5.2.1 | Specimens
A total of 23 vessels were obtained at two centers, ErasmusMC and Bristol Heart institute. We obtained 
17 coronary arteries from the Department of Pathology of the Erasmus MC at autopsy. Consent was 
obtained from the relatives and the protocol was sanctioned by the Medical Ethics Committee of the 
Erasmus MC. The coronary arteries were frozen within 2h at -80°, then thawed and measured within 
2 months. In the measurement, we fixed the specimen on top of a custom built plastic tissue holder with 
an array of 200 µm thick metal wires glued to the bottom at 1.5 mm intervals [21]. Whole cadaveric 
hearts used were obtained from the Bristol Heart Valve Bank and excised within 48 hours post-mortem 
and stored at 4°C [22]. A short guide catheter was introduced into the right coronary artery to facilitate 
intravascular imaging and fixed in position with sutures. All tissues were handled in accordance with 
the local ethics regulations. The heart specimen was held within a custom-built Perspex container, with 
adapters on both sides of the lid allowing connection of the guide internally, and a Y-connector and 
pressure/injector manifold externally [22]. For the study a total of 6 heart specimens were imaged. 
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5.2.2 | IV-OCT imaging
The OCT system used for imaging at both the Bristol Heart Institute and the Erasmus MC institutes 
was a C7-XR with Dragonfly catheter (St. Jude Medical Inc. St. Paul, MN, U.S.A), performing pullback 
acquisitions at a rate of 100 frames per second and a pullback speed of 20 mm/s. For experiments 
at Erasmus MC, the tissue holder was placed inside a water tank filled with saline solution at room 
temperature and pullback data was obtained. At the Bristol Heart Institute, the imaged artery was 
perfused with phosphate buffered saline (PBS) and the intracoronary pressure was maintained at 
100 mmHg. The end of the guide catheter served as a reference point. 
5.2.3 | Histology and plaque characterization
The histologic processing at Erasmus MC used the following protocol: After imaging, the arteries were 
cut at the two wires adjacent to the imaging plane, embedded in optimal cutting temperature compound 
(Tissue-Tek®, Sakura Finetek Europe B.V.), and then were frozen on dry ice, and stored at -80°C until 
further processing. For histopathology, a series of 10 µm thick sections were thaw mounted on slides and 
stained with Oil Red O (ORO) to identify lipids in the artery (lipids are stained red in ORO staining), 
Haematoxylin and Eosin (H&E), Cluster of Differentiation 68 (CD68) and Resorcin-Fuchsin (RF).
At the Bristol Heart institute, the imaged vessels were pressure-fixed while still on the heart with buffered 
formalin at 100 mmHg for 15 minutes, excised from the heart, and fixed with buffered formalin for 
24 hours. Then the vessels were embedded in paraffin and cut into 4-mm blocks with the end of the 
guide catheter serving as a reference. The proximal face of each block was cut at 3 µm thickness for 
histological analysis and serial sections stained with Haematoxylin and Eosin (H&E), Elastic Van Gieson 
(EVG), Cluster of Differentiation 68 (CD68) and smooth muscle cell α-Actin stains. CD68 and α-Actin 
were visualized using mouse anti-CD68 (DAKO M0814 and M0876 mixed 1/200 of each), and mouse 
anti-α actin (DAKO, M0851 1/200), or matched mouse IgG control, followed by biotinylated goat anti-
mouse and extravidin-HRP conjugate with DAB staining.
Forty atherosclerotic plaques were identified from the ex-vivo specimens. Two skilled pathologists 
analyzed the plaque characteristics by the histological staining and classified the plaque type. The lesions 
were classified according to standard criteria (AHA). Differences in tissue type identification and plaque 
type characterization, if any, were resolved by consensus between the two observers.
5.2.4 | Image analysis
A 1 mm segment of OCT pullback (5 frames) corresponding to each plaque location was selected. 
The OCT frames were then analyzed with the different methodologies for tissue characterization. The 
overview of the methods and the tissue types detected are depicted in Table 5.1. 
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Table 5.1 |
Study Method Tissue types detected
Tearney et al. (2003) Normalized standard deviation in 
ROI
 – Macrophage infiltration in fibrous cap (14)
van Soest et al. (2010) Optical attenuation  – Macrophage infiltration
 – Lipid pool
 – Fibrotic/calcium (18)
Phipps et al.
(2015)
Bright spot detection based on 
depth, catheter position and SNR
 – Macrophage 
 – Interfaces between calcium and fibrous, 
calcium and lipids, and lipid pool and fibrous 
cap
 – Cellular fibrous tissue (15)
Athanasiou et al. (2014) Texture analysis, K-means, 
automatic thresholding and 
classification algorithm
 – Calcium
 – Lipid tissue
 – Fibrous tissue
 – Mixed tissue (20)
5.3 | Results and discussion
5.3.1 | Lipid tissue
A total of 23 plaques were characterized as having lipid histologically. Image texture and attenuation 
imaging methods can detect lipid tissue or lipid pool and bright spots algorithm detects the interface 
of lipid with other tissue components. Both Image texture and attenuation imaging methods had good 
sensitivity and specificity for lipid tissue. The attenuation imaging method performs well in segments 
with relatively thin fibrous cap over the lipid. The deeper lipids result in a false negative prediction. Also 
in segments with large amount of macrophage presence, the high attenuation was mostly due to the 
macrophages. In these segments Image texture tends to overestimate the lipid content and shows false 
positives for the internal elastic media layer (IEM) of the vessels. Bright spots method resulted in bright 
spots at the interface between lipid and fibrous tissue but with a significant underestimation in terms of 
both the presence and the extent of lipid in the segments. NSD analysis is not aimed at lipid detection 
but some elevated NSD areas were found in plaque segments that had highly attenuating lipid with no 
histological presence of macrophages.
5.3.2 | Macrophages
Macrophages were present in 30 segments overall and two of the four compared methods, NSD analysis 
and bright spots, have macrophages as their major target tissue. The NSD analysis method detected all 
of the macrophage tissue present superficially and not the deep infiltrated macrophages, as the method 
requires selecting a ROI in the fibrous cap of the plaque. The method of Bright spots resulted in bright 
spots in the most of the region of macrophages but significantly less or no spots when the density of 
infiltration is less. Image texture do not have a classification for macrophages. The superficial macrophage 
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infiltrations are classified as mixed tissue and the deeper infiltrations as lipid tissue. Macrophages are the 
most attenuating tissue type and hence attenuation imaging’s attenuation coefficient method performs 
very well in macrophage detection. Only a couple of segments with deeper infiltrations resulted in false 
negatives. 
Figure 5.1 | A) Optical coherence tomography image showing a lipid rich plaque B) ORO stain showing the 
presence of lipid C) Attenuation image of the cross section using the method of attenuation imaging showing 
high attenuation in the lipid rich region. D) NSD image using the analysis of NSD analysis E) color-coded image 
produced using Image texture ( Red: lipid, White: calcium, green: fibrous tissue and light green: mixed tissue). 
F) Bright spot algorithm of Bright spots depicting few bright spots at the interface of fibrous and lipid tissue. 
G) H&E stain of the corresponding cross section.
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Figure 5.2 | A) Optical coherence tomography image showing a plaque with macrophage infiltration B) CD68 
stain showing the presence of macrophages C) Macrophages exhibiting high attenuation in the attenuation image 
of the cross section using the method of attenuation imaging D) Quantitative macrophage content from the NSD 
analysis of NSD analysis E) color-coded image produced using Image texture (Red: lipid, White: calcium, green: 
fibrous tissue and light green: mixed tissue). Macrophages are shown as mixed tissue F) Bright spot algorithm 
of Bright spots depicting few bright spots corresponding to the macrophage infiltration. G) H&E stain of the 
corresponding cross section.
5.3.3 | Calcium
Among the methods compared, Image texture’s algorithm is the only method that has classification for 
calcium. The bright spot method from Bright spots can also detect the presence of calcium indirectly 
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at the interface with fibrous or lipid tissue. Mixed plaque with regions of calcium and lipid resulted in 
bright spots but the calcium-fibrous interface almost resulted in no bright spots. Image texture algorithm 
detected calcium not mixed with lipid better than the calcium in mixed plaque. Only 8 segments in total 
had calcium.
5.3.4 | Fibrous
Fibrous tissue is relatively homogenous, high backscattering and the least attenuating plaque component. 
Low attenuation coefficients were depicted by attenuation imaging algorithm for all the segments but for 
two segments exhibiting high attenuation. In image texture method fibrous tissue is found often present 
along with mixed tissue even in cases with no histology evidence of mixed plaque. The NSD analysis also 
showed up some false positives in region with only fibrous tissue.
5.3.5 | Overview
Algorithmic OCT tissue type characterization can provide a valuable metric for automated assessment of 
the extent and severity of atherosclerotic coronary artery disease. The methods included in this study all 
have assets that make them valuable contributions to the image analysis toolbox in clinical OCT imaging. 
With the exception of the image texture classification, all of these algorithms have been developed and 
tested on histological data sets. This comparative study shows that the NSD, bright spot and attenuation 
analyses all detect the tissues that they aim to identify, but also have limited specificity, as is evident from 
the false positives arising for macrophages in NSD and lipid tissue in the attenuation method. The bright 
spots algorithm does not aim to identify the nature of the detected bright spots but only to investigate 
the utility of this image feature as a measure for plaque heterogeneity and inflammation. This study is the 
first to compare texture-based tissue characterization with histology, and it demonstrates a reasonable 
correspondence, with the caveat that the classification tends to indicate lipid in all areas of signal loss, 
which leads to an overestimation.
It is interesting to evaluate a hybrid approach, such as the one pioneered by the Leuven group [23], 
which combines attenuation analysis with classification based on local image statistics. Like the image 
texture analysis, it has not been evaluated on ex vivo data before. We aim to include this analysis in the 
near future.
The methods have a few limitations. The methods are either image based or optical parameter retrieval 
by analyzing the OCT data and hence they also inherit the intrinsic limitations of OCT. OCT has limited 
tissue-penetration which makes the analyses made on the OCT image beyond certain depth as unreliable. 
OCT also suffers from artifacts that can resemble the morphology or texture of a plaque tissue type, 
such as tangential signal drop or catheter proximity. Moreover atherosclerosis is a complex progressive 
disease and classification of tissues, both on histology and images is necessarily a simplification. Future 
research should provide more insight into which image features have prognostic value or may be used 
for intervention guidance.
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Some methods require manual selection of ROIs (NSD works on fibrous caps only, attenuation requires 
the media contour), which can be time consuming and limits automation. This may be addressed by 
automatic segmentation algorithms [24,25] that are continuously being refined.
5.4 | Conclusions
Each of the methods of OCT tissue characterization compared, has value as an atherosclerotic tissue 
component detection tool and could play a significant role in the assessment of the stability of the plaque. 
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Abstract
Background: Although recent observations suggest a favorable healing process of the everolimus-eluting 
bioresorbable vascular scaffold (BVS), little is known regarding the long-term healing response.
Objective: We assessed the in vivo vascular healing response 5 years following elective first-in-man BVS 
implantation by optical coherence tomography (OCT).
Methods: Out of 14 living patients enrolled in the Thoraxcenter Rotterdam cohort of ABSORB A study, 
eight patients underwent invasive follow-up including OCT, 5 years post implantation. Advanced OCT 
image analysis included luminal morphometry, assessment of the adluminal signal-rich layer separating 
the lumen from other plaque components, visual and quantitative tissue characterization, and assessment 
of side-branch ostia jailed at baseline.
Results: In all patients, BVS struts were integrated in the vessel and not discernible. Both, minimum and 
mean luminal area increased from 2 to 5 years, while lumen eccentricity decreased over time. In most 
patients plaques were covered by a signal-rich, low-attenuating layer. The minimum cap thickness over 
necrotic core was 155±90 μm. One patient showed different tissue response with plaque progression 
and discontinuity of this layer. Side-branch ostia were preserved with thinning of tissue bridges that had 
developed in the place of side-branch struts creating a ‘neo-carina’.
Conclusions: At long-term BVS follow-up, a favorable tissue response is observed, with late luminal 
enlargement, side-branch patency, and development of a signal-rich, low-attenuating tissue layer 
covering thrombogenic plaque components. The small scale of our study and the observation of a 
different tissue response in one patient warrant the judicious interpretation of our results and further 
confirmation in larger studies. 
Abbreviations
BVS: bioresorbable vascular scaffold
ICC: intraclass correlation coefficient
IEL: internal elastic lamina
IQR: interquartile range
IVUS: intravascular ultrasound
LAD: left anterior descending artery
LCx: left circumflex artery
OCT: optical coherence tomography
OM: obtuse marginal branch
SB: side-branch 
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6.1 | Introduction
Metallic stents for percutaneous revascularization have been associated with late complications, such as 
neoatherosclerosis, late restenosis and thrombosis [1]. Bioresorbable vascular scaffolds (BVS) could help 
overcome such pitfalls. In the ABSORB A study, the first-generation everolimus-eluting bioresorbable 
vascular scaffold (Absorb BVS 1.0; Abbott Vascular, Santa Clara, CA, USA) was associated with a good 
long-term clinical outcome after 2 and 5 years [2,3]. Plaque regression from 2 to 5 years and recovery of 
vasomotion in the scaffolded segment were documented in a patient subset [4]. Moreover, recent clinical 
observations of a signal-rich layer separating potentially thrombogenic plaque components from the 
lumen [5,6], suggest a favorable long-term healing response with potential plaque sealing.
We aimed to provide a comprehensive optical coherence tomography (OCT) analysis of the vascular 
healing response in the longest follow-up available to date, namely after 5 years, in the first series of 
patients who received everolimus-eluting BVS.
6.2 | Methods
6.2.1 | Patient population
The study population [4] and index procedure [2] have been described (see supplementary material). 
Briefly, all living patients of the Thoraxcenter Rotterdam cohort of ABSORB A study (n=14) were asked 
to participate. Eight of them consented and were included. The protocol was approved by the institutional 
ethics committee and conforms to the declaration of Helsinki.
6.2.2 | OCT image acquisition
All 8 subjects underwent frequency-domain OCT at the 5-year invasive follow-up [7]. Six patients at 
baseline, 7 patients at 6-month follow-up, and 7 patients at 2-year follow-up had undergone occlusive 
time domain OCT as per ABSORB A study protocol, with serial OCT imaging at all intervals available 
for 5 patients. For details see supplementary material.
6.2.3 | Definitions
OCT analysis of bioresorbable scaffolds has essential differences from metal stents (Figure 6.1). In 
metal stents, struts are preserved and neointimal area is clearly defined as the area between stent and 
lumen contour. In BVS, when scaffold struts are still discernible, the neointimal area can be assessed 
similarly to metal stents. However, at long-term follow-up, scaffold struts are no longer visible and the 
area corresponding to struts and neointima has similar optical properties as the underlying fibrous layer 
[5,8]. Consequently, it is impossible to distinguish between strut area, neointimal area and underlying 
plaque. 
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Therefore, the vascular structure observed at the scaffolded segment as a product of the consolidation of 
underlying plaque, biodegraded struts and neointima resembles a native atherosclerotic plaque and was 
defined as neo-plaque (Figure 6.1).
Since the scaffold area, and thus neointimal area cannot be distinguished from the underlying plaque 
by OCT, neointimal thickness cannot be directly assessed. Hence, we aimed to provide an indirect 
assessment focusing on the signal-rich layer observed, consisting of the neointimal layer, resorbed struts 
and pre-existing fibrous tissue. Therefore, we analyzed this signal-rich layer for providing a measure of the 
separation of the lumen from underlying plaque components [5,6]. The signal-rich layer encompassed 
the area between lumen border and internal elastic lamina (IEL). In situations where signal-poor regions 
(calcifications, necrotic core, deeply located fibrous plaque) obscured IEL delineation, the signal-rich 
layer was delineated between lumen border and the boundary of signal-rich and signal-poor regions 
(Figures 6.1-6.2).
Figure 6.1 | Long-term vascular healing response in metal stents and bioresorbable scaffolds. After metal stent 
implantation, struts are preserved and the neointimal area is clearly delineated between stent and lumen contour 
even at long-term, with possible development of neoatherosclerosis within the neointima. Conversely, in long-
term follow-up of bioresorbable scaffolds, after bioresorption neointimal boundaries are unclear (dotted line), and 
the intima resembles a native plaque, defined as ‘neo-plaque’. The ‘sealing layer’ is defined as the layer separating 
the underlying plaque components from the lumen.
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6.2.4 | OCT image analysis
The region of interest was defined by the platinum scaffold markers. Quantitative and qualitative 
5-year OCT image analysis was performed per frame. Analysis included the assessment of discernible 
struts, lumen morphometry, signal-rich layer thickness measurement, neo-plaque characterization, 
attenuation analysis, and ostial side-branch assessment. Metal stents implanted in the same vessels were 
also analyzed [1].
6.2.5 | Luminal measurements and variability analysis
For details see supplementary material. Measurements included mean and minimum lumen area 
and eccentricity, calculated as the ratio [(maximum lumen diameter – minimum lumen diameter)/
maximum lumen diameter] [7]. Lumen measurements were assessed for intra-observer, inter-observer 
and intra-study variability.
6.2.6 | Quantification of signal-rich layer thickness
The signal-rich layer was quantified following segmentation of its luminal and abluminal contour, by 
measurement of minimum, mean and maximum thickness and symmetry (ratio of minimal-to-maximal 
thickness; Figure 6.2). Signal-rich layer measurements were assessed for variability.
6.2.7 | ‘Neo-plaque’ characterization
‘Neo-plaque’ morphology was assessed per frame at five years, according to native atherosclerosis 
definitions [7], and the arc of calcifications, necrotic core and mixed plaque was measured using 
QCU-CMS (LKEB, Leiden University, Netherlands; research version of QIvus, Medis medical imaging 
systems bv, Leiden, Netherlands). Fibrous cap contours were traced over necrotic core and minimum 
cap thickness was measured. Mean and minimum cap thickness was calculated per patient. Spread-out 
maps representing ‘neo-plaque’ morphology and cap thickness throughout the scaffolded segment were 
generated (Figure 6.3), and color-coded according to plaque type. The presence of sharply-delineated 
signal-poor voids, corresponding to intimal microchannels [7], was recorded.
In ‘neo-plaques’ with necrotic core, OCT images were compared with previous follow-ups, in order 
to investigate for any evidence of de novo accumulation of necrotic core of adluminal origin, possibly 
corresponding to neoatherosclerosis.
6.2.8 | Attenuation analysis
We used attenuation analysis for quantitative tissue characterization of the signal-rich layer and the 
‘neo-plaque’ (Figure 6.4). In ex-vivo validation experiments, highly-attenuating regions (attenuation 
coefficient μt≥8 mm-1) have been associated with necrotic core or macrophages. On the contrary, 
μt<6 mm-1 were associated with healthy vessel components, intimal thickening or calcified plaque [9,10]. 
Attenuation was quantified circumferentially at different depths from the lumen surface by custom-
made software [11]. Results were plotted in spread-out maps demonstrating 1) maximum attenuation 
coefficient per A-line throughout the pullback, and 2) attenuation coefficient values in different depths 
from the vessel surface.
503688-L-sub01-bw-Gnanadesigan
6
83Long-term OCT follow-up of BVS | 
4
Figure 6.3 | Plaque characterization and cap tracing. In frames with necrotic core, calcifications, or mixed plaque 
within the scaffolded segment, the overlying fibrous cap is segmented and minimum thicknesses are recorded. A 
spread-out map is generated, showing the component distribution within the ‘neo-plaque’, with lighter colours 
corresponding to thicker caps. GW, guidewire; arrowhead, scaffold marker
6.2.9 | Side-branch assessment
In order to assess anatomical side-branch jailing over time, three-dimensional images of side-branch ostia 
were obtained by volume-rendering software (Intage Realia, KGT, Japan) [1]. No struts were identifiable 
in OCT, but neointimal bridges had developed in their place. Neointimal bridges were classified based 
on their relative location to the ostium as proximal, distal, proximal and distal, or crossing (Figure 6.5). 
Mean and minimal thickness was measured in matched frames at 2-year and 5-year follow-up using 
QCU-CMS (Supplementary Figure 6.1).
Side-branch ostium area was assessed using dedicated software (QAngioOCT 1.0, Medis Specials bv, 
Leiden, Netherlands). Following three-dimensional reconstruction, a cut-plane perpendicular to the 
side-branch centerline was selected and side-branch ostium planimetry was performed (Figure 6.6) [13].
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6.2.10 | Statistical analysis
Continuous variables are presented as mean±SD, or median (interquartile range; IQR), and nominal 
variables as n, (%). Significance level was set at p<0.05. Luminal measurements were compared by 
Wilcoxon’s signed rank test. All other paired comparisons were performed by paired t-test. No corrections 
were made for multiple comparisons. Variability was assessed using intraclass correlation coefficients 
(ICCs) for absolute agreement and Bland-Altman statistics. Statistical analysis was performed with SPSS 
20.0 (IBM, Armonk, NY, USA).
6.3 | Resuts
6.3.1 | Lumen and strut measurements
No binary restenosis was witnessed in the 5-year angiograms. In all patients, scaffold struts were no 
longer discernible as a result of complete bioresorption, and lumen area increased significantly from 2 
to 5 years (Figure 6.7). Lumen eccentricity declined over time (baseline: 0.24±0.13; 6-month: 0.29±0.12; 
2-year: 0.21±0.08; 5-year: 0.15±0.02; p<0.05 for all comparisons versus previous studies).
Figure 6.7 | Serial luminal measurements.
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Despite an initial decrease in lumen dimensions from baseline to 6 months, (A) minimal and (B) mean 
lumen area are increased at 5 years compared to previous follow-ups and not significantly different than 
baseline.
The total strut count in five patients with serial observations was reduced from 278 at baseline, to 248 at 
6 months, to 174 at 2 years, and no visible struts at 5 years. Two cases with incomplete scaffold apposition 
at baseline or 6 months demonstrated complete resolution of incomplete scaffold apposition at 2 years, 
with complete strut bioresorption at 5 years.
6.3.2 | Quantification of signal-rich layer.
Median values [IQR] for mean, minimum, and maximum signal-rich layer thickness, and symmetry 
were 330 μm [290 μm-378 μm], 150 μm [120 μm–190 μm], 570 μm [500 μm–640 μm], and 0.26 
[0.20–0.33], correspondingly. Supplementary Figure 6.2 demonstrates frequency distributions of these 
thickness measurements. 
6.3.3 | ‘Neo-plaque’ characterization
Spread-out ‘neo-plaque’ maps are presented in Figure 6.8. The mean value of minimum cap thickness 
was 310±113 μm, while the minimum value was 155±90 μm. Mean and maximum values were 92±49° 
and 156±72° for necrotic core arc, 80° and 104° for calcification arc, 104±145° and 146±80° for mixed 
plaque arc.
Microchannels were identified in 7/8 patients and in 66/468 frames (14.1%). As seen in the ‘neo-plaque’ 
maps, necrotic core or mixed plaque >1 quadrant was observed in 7 patients. Comparison with previous 
follow-ups did not reveal evidence of de novo necrotic core accumulation of adluminal origin.
Two patients had a focally irregular lumen contour: Patient 8 had a short intimal dissection, not present 
at earlier investigations, at the overlap between BVS and a metallic stent implanted at baseline. We 
assume that this minor, angiographically not visible dissection is most likely iatrogenic, induced by the 
guidewire. In Patient 4, a thin cap fibroatheroma was observed at the distal scaffold segment with cap 
disruption and small thrombus (Figure 6.9). This patient had undergone implantation of a 3.0x12 mm 
BVS, after 2.5x8 mm balloon predilation, further post-dilated with a 3.0x8 mm balloon. Post-hoc 
revision of previous OCT examinations revealed possible scaffold discontinuity near the distal edge at 4 
months, with the scaffold being dislocated opposite to the rupture site. During 2218-day follow-up, the 
patient underwent uneventful revascularization of a flow-limiting lesion (fractional flow reserve: 0.79) 
5mm distal of the BVS with a 3.0x2.5x19 mm Tryton bifurcation stent (Tryton Medical, Newton, MA) 
also covering the scaffolded segment.
6.3.4. | Attenuation analysis
Mean attenuation per patient within the signal-rich layer was 1.77±0.32 mm-1 and the median was 
1.28±0.25 mm-1 (Supplementary Figure 6.3). This value was higher within the entire ‘neo-plaque’ (mean 
per patient: 2.87±0.54 mm-1, median per patient: 2.33±0.49 mm-1, p<0.001; Supplementary Figure 
6.4). Spread-out attenuation maps at different depths from the luminal surface (100μm, 200 μm, and 
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400 μm) are displayed in Figure 6.10. The surface layers (first 200 μm) had low attenuation, overlying 
high-attenuation areas located deeper in the plaque.
Figure 6.8 | Neo-plaque morphology. Spread-out maps from all patients demonstrating ‘neo-plaque’ composition. 
Red represents necrotic core, orange mixed plaque, and white calcification. Lighter colours indicate a thicker 
fibrous cap (>250 μm). The minimum and mean values of minimum cap thickness per patient are presented in 
white and yellow, respectively.
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Figure 6.9 | Vascular response in Patient 4. At baseline, there is malapposition (white arrowheads) at the distal 
scaffold segment. At a follow-up examination at 106 days performed during non-target lesion revascularization, 
scaffold collapse (white arrowheads) at the site of the distal marker (white bullet), overhanging struts (yellow 
arrowheads), and thrombus (yellow arrow) were observed suggestive of late scaffold discontinuity. At 6 months, a 
tissue bridge was formed (white arrowheads) at the site of the collapsed scaffold, and integrated into the vascular 
wall by 24 months. There is also macrophage accumulation (white asterisks) at the opposite side at 24 months. At 
a subsequent 60-month follow-up, lesion progression with macrophages and necrotic core was evident, as well as 
intimal disruption. At the 72-month study follow-up, there is further luminal narrowing and plaque rupture with 
thrombus (white arrow). Abbreviations: GW, guidewire; NC, necrotic core.
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Figure 6.10 | Attenuation spread-out maps in different depths from the vessel surface. Spread-out maps 
demonstrating the attenuation coefficient in certain depths from the vessel surface (100 μm, 200 μm, and 400 μm) 
per patient. In the majority of patients, there is a low-attenuating layer of 200 μm, separating the underlying 
plaque (starting at ~400 μm) from the lumen. In Patient 4, this layer is absent and the plaque is close to the lumen.
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6.3.5 | Side-branch assessment
All side-branches were patent with TIMI III flow. Overall, 14 side-branches were associated with 
incompletely apposed struts at previous examinations. Neointimal bridges at 5 years were identified in 
13 side-branches, whereas in one no bridge was visible (Table 6.1).
Minimal and mean thickness of neointimal bridges overlying side-branches were respectively 
reduced from 241±92 μm and 341±106μm at 2 years to 161±107 μm and 227±119 at 5 years (p<0.001; 
Supplementary Figure 6.5). 
Table 6.1 | Side-branch analysis.
Bifurcation type SB ostium area(mm2) Jailing pattern
Patient 1-SB 1 OM-LCx 4.81 Proximal and distal
Patient 2-SB 1 LAD-septal 6.22 Crossing
Patient 2-SB 2 LAD-diagonal 1.14 Distal
Patient 2-SB 3 LAD-septal 1.89 Proximal
Patient 3-SB 1 LAD-diagonal 1.58 Distal
Patient 3-SB 2 LAD-septal 1.42 N/A*
Patient 4-SB 1 LCx-OM 1.11 Proximal and distal
Patient 5-SB 1 LAD-septal 1.93 Crossing
Patient 5-SB 2 LAD-diagonal 0.46 Distal
Patient 6-SB 1 LCx-OM 1.37 Crossing
Patient 6-SB 2 OM-LCx 2.23 Distal
Patient 8-SB 1 LCx-OM N/A† Proximal
Patient 8-SB 2 LCx–posterolateral 0.3 Proximal
Patient 8-SB 3 LCx-OM 0.78 Proximal
*The bridge was not present at 5 years ‒ distal location at previous studies. †Exact area not measurable. Abbreviations: SB, side-branch; 
OM, obtuse marginal branch; LCx, left circumflex artery; LAD, left anterior descending artery.
6.3.6 | Metal DES analysis
Metal DES analysis is presented in Supplementary Table 6.1 and Figure 6.11. In Patient 1, there was a focal 
distal edge stenosis of a distally overlapping 3.0x13 mm SES (luminal area:1.74 mm2) left untreated. In 
all metal stents, coverage was >95%, without malapposed struts, while neoatherosclerosis was identified 
in all.
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6.3.7 | Variability analysis
Inter- and intra-observer variability for both frame- and patient-level analysis was low (inter-observer: 
difference 0.23±0.29 mm, ICC 0.98; inter-observer [core-lab]: difference 0.13±0.32 mm, ICC 0.98; intra-
observer: difference 0.17±0.19 mm, ICC 0.99) (Supplementary Table 6.1; Supplementary Figure 6.6). As 
seen in the Bland-Altman plots, there were few measurements with significant differences, all of which 
in the polygon of confluence of larger side-branches with complex geometry lacking a priori definitions 
for contour tracing. ICCs for mean and minimal signal-rich layer thickness were respectively 0.95 and 
0.86 for intra-observer, and 0.80 and 0.80 for inter-observer variability.
Figure 6.11 | Representative OCT images of metal drug-eluting stents. A) Covered struts (green bullet), B) 
Neoatherosclerosis, C) Distal edge stenosis (area=1.74 mm²). D) Heterogeneous neointima with discontinuity 
(white arrow), E) Neoatherosclerosis, F) Neointimal disruption (yellow arrow) over necrotic core with mural 
thrombus. G) Evaginations - neointimal discontinuity (white arrow) possibly iatrogenic, H) Uncovered strut (red 
bullet), I) Neoatherosclerosis. Abbreviations: GW, guidewire; NC, necrotic core.
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6.4 | Discussion
We present the first in-vivo long-term OCT data 5 years after BVS implantation. Despite the small 
sample size, these first patients treated with BVS offer a unique opportunity to study the long-term 
vascular response after BVS implantation (Figure 6.12). Our main findings are that 5 years post BVS 1.0 
implantation: 1) there is late lumen enlargement with simultaneous increase in luminal symmetry; 2) all 
struts have disappeared and been integrated within the neointima and the underlying plaque, forming 
a homogeneous, signal-rich, low-attenuating layer; 3) this signal-rich layer separates the lumen from 
the underlying plaque with a minimum thickness of 150 μm (IQR:120 μm–190 μm); 4) this effect is 
not universal, as there was one case with thinning and disruption of the signal-rich layer; 5) jailed side-
branch ostia are preserved, while side-branch related struts have been replaced by thin tissue bridges; 
and 6) metal DES in the same vessels are lacking a distinct signal-rich layer and show neoatherosclerosis 
despite good coverage and apposition.
In our series, we observed a consistent luminal enlargement from 2 to 5 years in all patients. Late luminal 
enlargement in bioresorbable scaffolds has been attributed to outward remodeling in animal studies 
[14], and plaque burden reduction in clinical trials [4,15]. Our findings echo larger scale intravascular 
ultrasound (IVUS) observations of lumen area increase from 6 months to 2 years after BVS implantation 
[2,15]. IVUS observations in our study population were consistent with our findings, showing a trend 
for further lumen enlargement from 2 to 5 years, driven by a persistent decrease in plaque size from 6 
months to 2 years either as a result of true plaque regression or pseudo-regression due to strut resorption 
[2,4]. A similar trend was also observed in the 5-year multi-slice computed tomography follow-up of 
ABSORB A [3]. Moreover, in our study, we observed a recovery of luminal symmetry. Although its 
clinical significance is unclear, simultaneous observations of strut bioresorption and signal-rich layer 
development suggest a potentially favorable biological effect. This is in accordance with IVUS studies 
showing increased plaque rupture in eccentric vessels [16]. The observed complete strut bioresorption 
is in line with vasomotion findings demonstrating a lack of mechanical vessel constraint, with positive 
acetylcholine response in 4 patients, negative response in 2 patients, and absence of significant change 
in only 2 patients [4].
It has been suggested that neointimal growth after BVS resorption could serve as a mechanical barrier 
preventing potentially thrombogenic plaque components from reaching the bloodstream, a concept 
dubbed ‘plaque sealing’ or ‘recapping the plaque’ [5,6]. With this hypothesis in mind, we scrutinized 
BVS morphology in our cohort, employing sophisticated algorithms for in-depth analysis.
We focused on the developed adluminal signal-rich layer, corresponding to neointima, bioresorbed 
struts and fibrous components of the underlying plaque. The minimum signal-rich layer thickness 
was 150 μm and the minimum cap thickness over necrotic core 155±90 μm, which are far beyond the 
65 μm threshold generally accepted as high-risk for plaque rupture [17], and suggests that this layer 
could reliably separate the lumen from potentially thrombogenic plaque components. Importantly, this 
layer showed remarkable homogeneity in the attenuation analysis, with low attenuation values hinting 
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to the absence of high-risk wall components such as necrotic core and macrophages within the layer 
[9,10]. Therefore we speculate that this signal-rich layer could be protective against very late scaffold 
thrombosis or de novo thrombosis by plaque progression and rupture [1,17]. 
The complete scaffold integration into the vascular wall has shaped a ‘neo-plaque’ phenotype as a result 
of the complex interaction of pre-existing plaque, morphological changes of the pre-existing plaque 
subject to dynamic local rheologic factors [18,19], strut resorption and neointima formation [8]. We 
visually characterized ‘neo-plaque’ using standardized OCT criteria [7]. Quantitative attenuation 
analysis corroborated these qualitative findings revealing co-localization of necrotic core regions with 
high attenuation regions (Supplementary Figure 6.7). High-attenuation regions were generally located 
deeper into the vessel wall and rarely observed within the first 200 μm from luminal surface. Of note, 
most patients were under intensive medical therapy (statins: 75%; beta-blockers: 75%; angiotensin 
receptor blockers: 62.5%), possibly contributing to this favorable phenotype.
Metal stents covered with well-organized and functional neointima can likewise present a mechanical 
barrier between underlying plaque and lumen. However, neointimal proliferation and neoatherosclerosis 
development over time have been consistently reported for BMS and even more accelerated for DES. The 
permanent nature of the metallic structure further massively limits the vessel’s ability for remodeling, 
plaque regression and lumen enlargement over time (as in BVS). In consequence, lumen narrowing 
develops inevitably over time. Indeed, 3 metal drug-eluting stents in our cohort all showed adluminal 
neoatherosclerosis, with minimum cap thickness ranging from 70 to 110 μm. This is notable, as thin 
fibrous cap emerges as risk factor for neointimal rupture and acute coronary syndrome not only in native 
atherosclerosis, but also in neoatherosclerosis [1]. 
We analyzed the fate of side-branches jailed by BVS, as high strut thickness and the observation of tissue 
bridge formation has raised questions regarding long-term patency [12]. Three-dimensional rendering 
demonstrated side-branch patency, allowed reliable ostial measurements, and identified different intimal 
bridge patterns. Strut integration into these tissue bridges was completed without visible remnants, 
accompanied by bridge thinning from 341±106 μm at 2 years to 227±119 μm at 5 years. We consider 
these findings, together with the angiographically confirmed absence of flow impairment as a favorable 
long-term outcome. However, the implications of BVS over large side-branches or in true bifurcation 
lesions, both in terms of implantation technique and long-term patency, have yet to be understood 
[20,21], as these were excluded per protocol.
Overall, our long-term OCT observations suggest, in these patients treated with BVS and receiving 
intensive medical therapy, a favorable vascular healing response with late lumen enlargement, increased 
luminal symmetry, side-branch patency, complete strut resorption and the formation of a potentially 
protective tissue layer, giving an appearance consistent with the hypothetical concept of plaque sealing.
However, Patient 4 showed a different response capturing our attention. We observed target lesion 
progression with OCT findings consistent with macrophage infiltration, abluminal necrotic core 
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accumulation, fibrous cap thinning and plaque rupture at follow-up. The patient was under treatment 
only with aspirin and clopidogrel. Revision of all available data revealed diffuse disease necessitating 
non-target lesion revascularization with a metal paclitaxel-eluting stent in the same artery, 106 days after 
BVS implantation. This paclitaxel-eluting stent developed subsequent neoatherosclerosis with neointimal 
disruption and micro-thrombus formation (Figure 6.11). This evidence of accelerated atherosclerosis, 
combined with mechanical factors (baseline incomplete scaffold apposition, followed by late structural 
discontinuity) might have contributed to this adverse ‘neo-plaque’ phenotype. Notably, the patient did 
not suffer a clinically apparent acute coronary syndrome regardless of these impressive findings.
Despite the limited scale of our study, it provides crucial information on the long-term vascular response 
5 years post BVS implantation. While we consider the overall vascular response favorable and in line with 
larger-scale clinical reports, there might be lessons to learn from observations in a single patient, who 
showed a different biological reaction with recurring plaque rupture after BVS implantation. This finding 
might underscore the need for an optimal acute mechanical result with optimal lesion coverage, while 
simultaneously raising questions regarding a possible responder/non-responder reaction to BVS and the 
need for intensified secondary prevention in selected patients in the future [22]. As such, our findings 
might guide further research for optimizing clinical efficacy of BVS in light of the 1.1 modifications and 
herald observations in more complex populations [23].
Study limitations: This is a small first-in-man study, containing only a fraction of patients of ABSORB A 
study. Selection bias cannot be excluded, although the baseline clinical and angiographic characteristics 
were not different from the entire ABSORB A cohort. BVS 1.0 assessed in our study differs in geometry 
and resorption rate compared to the currently used BVS 1.1, which might affect temporal course and 
pattern of the healing response. 
Attenuation analysis has only been validated in ex vivo specimens of native atherosclerosis, and not in 
device-induced tissue responses. However, as attenuation is an optical property of tissue components, we 
expect the absence of high-attenuating regions to correspond to absence of necrotic core or macrophages 
also in this setting.
Five-year OCT follow-up was performed with a non-occlusive frequency-domain system, whereas 
previous OCT examinations with an occlusive time-domain system. Frequency-domain OCT offers 
better image quality and higher dynamic range, allowing superior visualization of deeply located 
plaques [24]. Due to these limitations of time-domain systems, serial assessment of plaque morphology 
behind the BVS was not systematically performed, and only examined with reference to possible 
neoatherosclerosis, although changes over time would be expected [19]. Occlusive time-domain OCT 
slightly underestimates lumen area [25]. Nevertheless, 4 patients in our study underwent additional 
non-occlusive OCT imaging at 2-year follow-up. Comparing non-occlusive data at 2 years to 5-year 
non-occlusive data, findings of late lumen enlargement were consistent, albeit not reaching significance 
due to smaller sample size (minimum lumen area: 3.54±1.43 mm² at 2 years versus 4.06±1.33 mm² at 
5 years, p=0.14; mean lumen area: 5.12±1.62 mm² at 2 years versus 5.95±1.20 mm² at 5 years, p=0.07).
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6.5 | Conclusions
At long-term follow-up 5 years after BVS implantation, a favorable tissue response is observed with late 
luminal enlargement, complete strut bioresorption and development of a low-attenuating, signal-rich 
layer covering underlying potentially thrombogenic plaque components. The small scale of our study 
and the observation of a different tissue response in one patient warrant the judicious interpretation of 
our results and further confirmation in larger studies.
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Perspectives
Competency in Medical Knowledge. At long-term after bioresorbable scaffold implantation, we 
observed complete strut resorption and a favorable vascular healing response with late lumen 
enlargement, increased lumen symmetry, side-branch patency and the formation of a potentially 
protective tissue layer, giving an appearance consistent with the hypothetical concept of plaque 
sealing.
Competency in Patient Care. While the overall vascular healing response after bioresorbable 
scaffold implantation was favorable, a single patient showed a different biological reaction with 
recurring asymptomatic plaque rupture after bioresorbable scaffold implantation. This finding 
might underscore the need for an optimal acute mechanical result with optimal lesion coverage, 
while simultaneously raising questions regarding a possible responder/non-responder reaction to 
bioresorbable scaffolds and the need for intensified secondary prevention in selected patients in 
the future.
Translational Outlook. Our first-in-man, mechanistic study confirmed the concept of 
biodegradation accompanied with beneficial structural and compositional plaque changes. 
We demonstrated late lumen enlargement with development of a layer separating potentially 
thrombogenic plaque components from the lumen at long-term after bioresorbable scaffold 
implantation. Our observations warrant a more widespread clinical evaluation of BVS, as these 
observed effects could be associated with a long-term benefit for the majority of lesions and patients.
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Abstract
Background: Despite the well-described association between plaque morphology and acute coronary 
syndromes, there is limited in vivo evidence regarding the temporal evolution of non-culprit coronary 
plaque morphology. We evaluated changes in non-culprit plaque morphology over time by optical 
coherence tomography (OCT).
Methods and Results: 119 patients had undergone serial OCT examination of the same vessel in our 
institution between 1/1/2009 and 31/8/2014. Among those, 72 patients with 257 non-culprit segments 
fitted the inclusion criteria and were analyzed. Non-culprit coronary segments were matched between 
baseline and follow-up. OCT plaque characterization including automated attenuation analysis was 
performed for both time points and changes over a median follow-up of 6.2 months were evaluated. On 
segment level, lumen area decreased from baseline to follow-up, whereas fibrous cap thickness increased. 
Similarly, plaque attenuation indexes at follow-up were significantly decreased compared to baseline. In 
most segments (68.5%), plaque morphology did not change. Favorable change was observed in 18.4% of 
segments and unfavorable in 12.9%. There were no robust clinical predictors of favorable or unfavorable 
change in plaque morphology. Attenuation analysis supported the qualitative characterization, showing 
significantly different attenuation between different plaque types.
Conclusions: In non-culprit coronary segments of patients with coronary artery disease under standard 
medical therapy, fibrous cap thickness increases over time. However, in individual segments, there are 
observations of both plaque stabilization and destabilization, even within the same artery and patient. 
No clinical factor could reliably predict these changes, possibly implying a need for reconsideration of 
current hypotheses and adaptation of future study designs.
Keywords: thin-cap fibroatheroma; plaque rupture; plaque progression; coronary artery disease; optical 
coherence tomography
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7.1 | Introduction
Vast post-mortem evidence suggests that morphological plaque characteristics such as thin fibrous cap 
and large necrotic core are implicated in plaque destabilization and triggering of plaque rupture [1,2]. 
However, despite this well-described association, prospective studies have only demonstrated a modest 
prognostic significance of plaque morphology for the prediction of future patient-level or lesion-level 
events in patients receiving optimal medical therapy [3-5]. Reasons for this discrepancy potentially 
include a high prevalence of such plaques and/or low specificity of intravascular imaging. In order to be 
able to enhance the prognostic capability of plaque characterization, a better in vivo identification of the 
true high-risk plaques is a prerequisite. Thus, it is necessary to further define the in vivo morphological 
characteristics associated with plaque progression, and document the morphological changes of 
atherosclerotic plaques over time under medical therapy.
Optical coherence tomography (OCT) is a high-resolution intravascular imaging modality which 
allows a comprehensive morphological characterization of the atherosclerotic plaque6. Morphological 
characterization can be further corroborated by automated plaque characterization software, such as 
quantitative attenuation analysis that provide a more objective assessment of plaque morphology [7].
We aimed to evaluate the changes in plaque morphology of non-culprit lesions over time by OCT using 
a qualitative and a quantitative approach, and further identify factors that are associated with these 
changes.
7.2 | Methods
7.2.1 | Study protocol
The OCT database of Erasmus MC was screened for patients undergoing serial OCT examinations of the 
same vessel with an interval >3 months. Patients, in whom the same non-culprit native atherosclerotic 
segment was visualized in both time points, were included in the study. The pullbacks were matched to 
each other using landmarks and synchronized by an automated algorithm (QCU-CMS, LKEB, Leiden, 
the Netherlands). OCT analysis was then performed in the matched vessel region, and changes from 
baseline to follow-up were recorded. Analysis was performed on a patient-level basis (entire imaged 
vessel) and on a segment-level basis (the imaged region was divided in equal sub-segments of 5mm and 
OCT morphology was assessed separately for each sub-segment). Additionally to conventional plaque 
characterization by visual assessment of the intensity map image, quantitative plaque characterization 
was performed by automated attenuation analysis. Demographic and clinical data were collected 
retrospectively. Informed consent was acquired from all patients for use of their imaging data and the 
study complies with the declaration of Helsinki.
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7.2.2 | Study population
All patients >18 years old that underwent serial OCT examination of the same vessel for clinical or 
research purposes in Erasmus MC between 1 January 2009 and 31/8/2014, with an interval of >3 months 
between the two examinations were screened for inclusion. Patients, in whom the same non-culprit 
native coronary artery segment of at least 5 mm length and located >5 mm beyond the edge segment of 
a previously implanted device was identified in both pullbacks, were finally included. Exclusion criteria 
were invasive treatment of non-culprit lesion in the interval between baseline and follow-up, poor image 
quality not allowing assessment of plaque morphology in at least 3 quadrants of the cross-sectional 
image, and saphenous vein graft lesions.
7.2.3 | OCT analysis
7.2.3.1 | Selection of region of interest (ROI) and segment matching
Matching was performed using dedicated software (QCU-CMS). Baseline and follow-up pullbacks 
were simultaneously reviewed for identification of a matched native coronary segment. Identification 
of the segment was based on anatomic (side-branches) or device-specific (stent edges) landmarks. As 
longitudinal catheter motion does not allow precise co-registration by the use of a single landmark 
and length information [8], multiple landmarks were selected, and segment co-registration was 
automatically performed. This allowed for a synchronized scrolling between the two pullbacks, used to 
identify the frame numbers corresponding to the same non-culprit native coronary segment in the two 
pullbacks, thus comprising the region of interest (ROI). For the segment-level analysis, the baseline ROI 
was divided in 5 mm sub-segments, which were matched between the two pullbacks after identification 
of corresponding frames by synchronized scrolling.
7.2.3.2 | Lumen measurements
Lumen measurements were performed at 1mm intervals within the ROI and mean and minimal lumen 
area were calculated for patient and segment level.
7.2.3.3 | Plaque analysis
Plaque morphology was also assessed for patient and segment level at 1mm intervals within the ROI, 
using commonly accepted definitions [9]. The presence of necrotic core or calcium was recorded and the 
corresponding arc (in º) was measured. Measurements included mean and maximum necrotic core and 
calcium arc, and also relative volumetric indexes of necrotic core and calcium content.
The relative necrotic core index (RNCI) was calculated as: 
RNCI=(mean necrotic core arc x necrotic core length) / (360 x analyzed length).
Similarly, the relative calcium index (RCI) was calculated as:
RCI=(mean calcium arc x calcium length) / (360 x analyzed length).
In cases of necrotic core, the overlying cap was measured over its entire surface by a semi-automated 
algorithm, with subsequent manual corrections if necessary. The minimum and average cap thicknesses 
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per patient and per segment were then calculated. Presence of macrophages, plaque rupture, and 
thrombus was also recorded [9,10].
7.2.3.1 | Interstudy variability
As analysis of matched segments might contain some bias of global measurements due to longitudinal 
catheter displacement [8], inter-study variability of the OCT measurements was calculated and only 
differences from baseline to follow-up that were higher than the limits of agreement were considered 
clinically relevant (online supplement).
7.2.3.1 | Hierarchical plaque characterization
Plaque characterization (Figure 7.1) was performed for patient and segment level using a hierarchical 
definition as follows:
a. Thin-cap fibroatheroma (TCFA): Maximum necrotic core arc >90º and minimal fibrous cap 
thickness ≤65 μm.
b. Fibroatheroma: Maximum necrotic core arc >90º and fibrous cap thickness >65 μm.
c. Fibrocalcific: Maximum calcium arc >90º, with maximum necrotic core arc ≤90º.
d. Fibrous: Maximum necrotic core arc ≤90º and maximum calcium arc ≤90º.
7.2.4 | Attenuation analysis
We further applied quantitative plaque characterization by attenuation analysis to corroborate findings 
from conventional OCT analysis [11]. The attenuation coefficient is a robust tissue optical parameter, 
which is increased in tissue types associated with plaque vulnerability, such as necrotic core and tissue 
macrophages, compared to more stable tissue types such as calcium and fibrous tissue [11,12]. Values 
of tissue attenuation for the entire perimeter of each cross-section for the entire studied segment were 
graphically plotted in a longitudinal attenuation map of the vessel. This mapping display of OCT depicts 
tissue optical properties in the entire pullback, demonstrating the maximum attenuation between lumen 
and intima-media border [13]. Thereby, a quantitative metric, namely the Index of Plaque Attenuation 
(IPA) is derived. IPA is a global metric of attenuation and is calculated as the fraction of pixels in the 
attenuation map with an attenuation coefficient greater than a certain threshold x, multiplied by a factor 
of 1000. The calculation of IPA can be represented as a mathematical formula as follows:
  IPAx=          X1000N(μt>x)Ntotal  (1)
where the numerator includes pixels with attenuation greater than certain threshold x. For this study, the 
IPA6 and IPA11 indexes were calculated. IPA6 has been associated with fibroatheroma morphology and 
IPA11 has been associated with TCFA morphology [14].
7.2.5 | Statistical analysis
All analyses were performed with SPSS 20.0 (IBM, Chicago, IL). Continuous variables are presented 
as mean±SD or median [interquartile range], while categorical variables are reported as count and 
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percentages. Statistical analysis was performed using mixed model regression and is described in the 
online supplement. All p-values are two-sided with a value <0.05 indicating significance.
7.3 | Results
A total of 119 patients had undergone serial OCT examination of the same vessel with an interval >3 
months between 1st January 2009 and 31st August 2014 and were screened for inclusion. Thirty four 
were excluded due to inadequate length of the matched segments, four due to visualization of a different 
branch not allowing matching, six due to OCT imaging in a graft, two due to poor image quality, and 
one patient due to performance of intervention in the studied segment between the two OCT studies. 
Overall, 72 patients fitted the criteria and were included.
Baseline clinical characteristics are reported in Table 7.1. Mean age was 59.0±11.0 years and 81.9% were 
male. Initial presentation was stable angina in 40.3% and acute coronary syndrome in 58.4%.
The median follow-up interval was 6.2 months[IQR 6.0-11.1 months]. In total, a mean vessel length of 
17.83±9.22 mm and 17.65±9.00 mm were analyzed for baseline and follow-up, respectively.
7.3.1 | Changes in OCT morphological characteristics
7.3.1.1 | Patient-level analysis
Mean lumen area was decreased at follow-up (7.87±3.68 mm2 versus 8.22±3.63 mm2 at baseline; p=0.049). 
However, no changes were observed in patient-level OCT plaque morphology (Table 7.2). Similarly, there 
were no differences on patient-level attenuation metrics, with the exception of a borderline decrease of 
IPA11 at follow-up (p=0.049). Clinically relevant changes in lumen dimensions, calcium arc and cap 
thickness were observed in a minority of patients on a patient level (30-35%), however more than half of 
the patients had significant differences in the maximum necrotic core arc, with one third of the patients 
presenting with increase of the necrotic core content (Table 7.3).
7.3.1.2 | Segment-level analysis
Overall 257 non-culprit segments were assessed (Table 7.2). Both minimal and mean lumen area were 
significantly decreased at follow-up compared to baseline (p=0.018 and p=0.005, respectively). There 
were no significant differences in necrotic core or calcium metrics between the two intervals. However, 
both minimum and average cap thickness were increased at follow-up compared to baseline (p=0.019 
and p=0.002, respectively). In addition, IPA6 and IPA11 values at follow-up were significantly decreased 
compared to baseline (p=0.036 and p=0.022, respectively). As with patient-level analysis, significant 
changes of lumen dimensions, and calcium arc were observed in a minority of segments (<40%) (Table 
7.3). However, more than half of the segments had significant changes in cap thickness and maximum 
necrotic core arc.
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Table 7.1 | Baseline characteristics.
Age (years) 58.98±10.95
Men n(%) 59(81.9)
Interval (months) 6.2[6.0-11.1]
Clinical presentation, baseline n(%)
 Stable angina
 Unstable angina
 STEMI
 NSTEMI
 Asymptomatic
29(40.3)
11(15.3)
28(38.9)
3(4.2)
1(1.4)
Clinical presentation, follow-up n(%)
 Stable angina
 Unstable angina
 NSTEMI
 Asymptomatic
12(16.7)
4(5.6)
1(1.4)
55(76.4)
Hypertension n(%) 34(48.6)
Diabetes n(%) 8(11.1)
Dyslipidemia n(%) 36(52.2)
Current smoker n(%) 27(37.5)
Family history of CAD n(%) 38(53.5)
Prior infarction n(%) 12(16.7)
Prior PCI n(%) 13(18.1)
Prior CABG n(%) 1(1.4)
Chronic kidney disease n(%) 2(2.8)
Vessel n (%)
 LAD
 LCX
 RCA
38(52.8)
20(27.8)
14(19.4)
Therapy n (%)
 ACE inhibitors/ARBs
 Statins
 Beta-blocker
37(51.4)
63(87.5)
39(54.2)
Baseline total cholesterol, mmol/L 5.01±1.13
Baseline LDL-C, mmol/L 3.40±1.10
Baseline triglycerides, mmol/L 1.26±0.90
Analyzed length baseline, mm 17.83±9.22
Analyzed length follow-up, mm 17.65±9.00
Values expressed as mean±SD, median[interquartile range], or n(%). Abbreviations: STEMI, ST-elevation myocardial infarction; NSTEMI, 
non-ST-elevation myocardial infarction; CAD, coronary artery disease; PCI, percutaneous coronary interventions; CABG, coronary 
artery bypass graft surgery; LAD, left anterior descending artery; LCx, left circumflex; RCA, right coronary artery; ACE, acetylholine 
converting enzyme; ARB, angiotensin receptor blocker; LDL-C, low-density cholesterol.
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Table 7.2 | Patient- and segment-level plaque morphology at baseline and follow-up. 
Baseline Follow-up p-value*
Patient-level
Minimal lumen area, mm2 5.24±2.86 5.28±2.93 0.76
Mean lumen area, mm2 8.22±3.63 7.87±3.68 0.049
Plaque morphology n(%) 0.81
 Fibroatheroma 30(41.7) 34(47.2)
 Fibrocalcific 0 0
 Fibrous 16(22.2) 16(22.2)
 TCFA 26(36.1) 22(30.6)
Mean necrotic core arc, (°) 99.9±35.6 96.7±35.4 0.21
Max necrotic core arc, (°) 170.9±67.4 174.1±79.7 0.67
RNCI, % 15.24±10.46 15.18±10.76 0.91
Mean calcium arc, (°) 72.1±51.0 62.0±42.8 0.25
Max calcium arc, (°) 100.7±83.8 90.6±82.9 0.31
RCI, % 1.87±6.03 1.85±6.75 0.92
Minimum cap thickness, μm 88±53 91±65 0.68
Average cap thickness, μm 183±62 209±67 0.01
IPA6, mm-1 480.71±144.97 464.36±152.76 0.48
IPA11, mm-1 52.40±41.00 44.73±36.23 0.049
Segment-level
Minimal lumen area, mm2 7.07±3.75 6.86±3.73 0.018
Mean lumen area, mm2 8.15±4.14 7.92±3.98 0.005
Plaque morphology n(%) 0.84
 Fibroatheroma 105(40.9) 110(42.8)
 Fibrocalcific 1(0.4) 0
 Fibrous 118(45.9) 123(47.9)
 TCFA 33(12.8) 24(9.3)
Mean necrotic core arc, (°) 96.7±43.0 94.8±39.1 0.48
Max necrotic core arc, (°) 133.7±65.0 135.4±71.0 0.81
RNCI, % 15.33±15.07 15.15±14.27 0.76
Mean calcium arc, (°) 76.9±59.9 82.5±56.4 0.59
Max calcium arc, (°) 98.4±83.9 108.6±89.5 0.34
RCI, % 1.59±6.11 1.79±7.03 0.38
Minimum cap thickness, μm 120±75 134±81 0.019
Average cap thickness, μm 184±80 206±83 0.002
IPA6, mm-1 472.77±179.94 444.52±185.86 0.036
IPA11, mm-1 49.46±52.42 42.72±45.74 0.022
Values expressed as mean±SD, or n(%). P-values derived from mixed model regression for repeated measurements. Abbreviations: RNCI, 
relative necrotic core index; RCI, relative calcium index.
503688-L-sub01-bw-Gnanadesigan
7
109Qualitative and quantitative evaluation of plaque progression by OCT | 
Figure 7.1 | Hierarchical plaque classification. Representative examples of: fibrous plaque, fibroatheroma, thin-
cap fibroatheroma and fibrocalcific plaque. Red lines denote the arc of the necrotic core, and the green line the 
cap segmentation. Abbreviations: NC, necrotic core; Ca, calcium. 
7.3.2 | Changes in hierarchical plaque morphology
The changes are summarized in Table 7.3 and Figure 7.2. 
7.3.2.1 | Patient-level analysis
In most patients (58.3%), plaque morphology did not change. In 25% plaque morphology had a favorable 
change (i.e. change from TCFA to fibroatheroma, or from fibroatheroma/TCFA to fibrous), while an 
unfavorable change (i.e. change from fibrous to fibroatheroma/TCFA, or from fibroatheroma to TCFA) 
was observed in 16.7%. Most fibrous plaques showed no change in morphology (81%). Interestingly, 
58% of the TCFA lesions were converted to fibroatheroma, while 30% of fibroatheromas gave rise to new 
TCFA lesions.
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Table 7.3 | Changes in OCT characteristics over time.
Patient-level (n=72) Segment-level (n=257)
MLA
Difference (follow-up – baseline), mm² 0.05(−0.26 to 0.35) −0.22(−0.39 to −0.04)
 Lumen expansion, n(%) 12(16.7) 35(13.6)
 No change, n(%) 47(65.3) 158(61.5)
 Lumen narrowing, n(%) 13(18.1) 64(24.9)
Max necrotic core arc
Difference (follow-up – baseline), º 3.4(−11.5 to 18.4) 1.0(−7.2 to 9.2)
 Increase, n(%) 15(20.8) 67(26.1)
 No change, n(%) 33(45.8) 124(48.2)
 Decrease, n(%) 24(33.3) 66(25.7)
Max calcium arc
Difference (follow-up – baseline), º −10.8(−30.3 to 8.7) 7.2(−8.0 to 22.4)
 Increase, n(%) 10(13.9) 32(12.5)
 No change, n(%) 50(69.4) 202(78.6)
 Decrease, n(%) 12(16.7) 23(8.9)
Minimum cap thickness
Difference (follow-up – baseline), μm 6(−12 to 24) 16(2 to 29)
 Increase, n(%) 12(19.0) 52(31.0)
 No change, n(%) 40(63.5) 81(48.2)
 Decrease, n(%) 11(17.5) 35(20.8)
Hierarchical morphology
 Favorable change, n(%) 18(25.0) 47(18.3)
  FA → fibrous 3(4.2) 21(8.2)
  TCFA → fibrous 0(0) 3(1.2)
  TCFA → FA 15(20.8) 23(8.9)
 No change, n(%) 42(58.3) 176(68.5)
  Fibrous → Fibrous 13(18.1) 99(38.5)
  FA → FA 18(25.0) 70(27.2)
  TCFA → TCFA 11(15.3) 7(2.7)
 Unfavorable change, n(%) 12(16.7) 33(12.8)
  FA → TCFA 9(12.5) 14(5.4)
  Fibrous → FA 1(1.4) 16(6.2)
  Fibrous → TCFA 2(2.8) 3(1.2)
Values expressed as estimate (95% confidence interval), or n(%).
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Figure 7.2 | Changes in hierarchical plaque morphology on A) patient level and B) segment level. Abbreviations: 
FA, fibroatheroma; TCFA, thin cap fibroatheroma; FC, fibrocalcific.
7.3.2.2 | Segment-level analysis
In line with patient-level data, 68.5% of segments showed no changes. Favorable change was observed 
in 18.4% of segments, and unfavorable change in 12.9%. Similarly to patient-level analysis, more than 
80% of fibrous plaques had no change in morphology, while the majority of TCFAs were converted to 
fibroatheromas, with the emergence of new TCFAs from 13% of the fibroatheromas at baseline. As a 
result of these dynamic changes, the overall percentage of lesions with a specific morphology did not 
change over time for patient-level or segment-level (Table 7.2).
7.3.2.3 | Predictors of change in plaque characteristics assessed by OCT
Predictors of change in MLA, maximum necrotic core arc, maximum calcium arc, and minimum cap 
thickness are reported in Supplementary Table 7.2. Prediction of these changes from clinical factors was 
poor. Interval between the two follow-ups was associated with decrease in MLA (p=0.004), whereas 
family history of CAD with increase (p=0.029). From angiographic variables, LCx lesions had higher 
MLA increase compared to RCA (p=0.043), while location distal to the stented segment was associated 
with decrease in maximum necrotic core arc compared to proximally located lesions (p=0.026). 
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Factors associated with favorable or unfavorable change in plaque morphology are presented in Table 
7.4. The only significant predictor of favorable change in plaque morphology was family history of CAD 
(p=0.009). Lesion location in LAD or LCx predicted less frequent favorable change and more frequent 
unfavorable change compared to RCA, however this difference did not reach significance.
Table 7.4 | Predictors of favorable and unfavorable change in plaque morphology.
Favorable
Odds ratio (95% CI)
Unfavorable
Odds ratio (95% CI)
Age (per year) 1.006(0.972-1.041) 1.003(0.962-1.046)
Male gender 1.485(0.498-4.431) 1.384(0.393-4.871)
Interval (per month) 0.955(0.897-1.018) 1.044(0.984-1.107)
Myocardial infarction at baseline 1.085(0.523-2.251) 1.096(0.467-2.574)
Hypertension 0.894(0.425-1.879) 1.121(0.481-2.615)
Diabetes 1.621(0.452-5.813) 1.039(0.199-5.431)
Dyslipidemia 0.638(0.303-1.346) 1.331(0.560-3.161)
Current smoker 0.936(0.343-2.557) 0.787(0.253-2.452)
Family history of CAD 0.383(0.188-0.781)* 0.617(0.264-1.441)
Statin use 3.188(0.673-15.096) 1.043(0.289-3.762)
Total cholesterol (per mmol/L) 1.447(0.752-2.784) 0.940(0.555-1.590)
Vessel
 LAD 0.457(0.174-1.198) 6.609(0.810-53.913)
 LCX 0.692(0.251-1.905) 3.383(0.372-30.747)
 RCA - -
Location relative to stent
 No stent in artery 1.452(0.418-5.046) 1.449(0.412-5.105)
 Distal to stent 1.842(0.855-3.968) 0.662(0.273-1.611)
 Proximal to stent - -
*p<0.05.
7.3.3 | Attenuation analysis and plaque morphology
Attenuation analysis per plaque type for patient- and segment-level analyses are presented in Table 
7.5. In both analyses, both IPA6 and IPA11 differed significantly between plaque types, with values of 
both attenuation coefficients higher for TCFA compared to fibroatheroma or fibrous, and higher for 
fibroatheroma compared to fibrous (all p-values <0.05). Table 7.6 presents the association of these 
indexes with OCT variables. Both indexes had a strong positive correlation with necrotic core metrics 
and a strong negative correlation with cap thickness (p<0.001).
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Table 7.5 | Association of hierarchical plaque classification with attenuation indexes.
Plaque  
morphology
Value p-value vs.  
FA
p-value vs.  
FC
p-value vs. 
fibrous
Patient-level
IPA6, mm-1 TCFA 533.6±134.7 0.019 <0.001
FA 485.206±122.4 0.015
Fibrous 364.5±156.4
IPA11, mm-1 TCFA 66.9±45.6 0.018 <0.001
FA 48.7±31.6 0.006
Fibrous 17.6±14.8
Segment-level
IPA6, mm-1 TCFA 605.3±127.7 0.013 0.163 <0.001
FA 516.4±143.5 0.315 <0.001
FC 398.1 0.903
Fibrous 359.6±189. 6
IPA11, mm-1 TCFA 89.5±66.5 0.002 0.601 <0.001
FA 53.4±46.7 0.891 <0.001
FC 14.0 0.827
Fibrous 30.0±60.7
Values expressed as mean±SD. P-values derived from mixed model regression. Abbreviations: FA, fibroatheroma; FC, fibrocalcific; TCFA, 
thin cap fibroatheroma.
Table 7.6 | Association of segment-level OCT variables with attenuation indexes.
IPA6 (mm-1) IPA11 (mm-1)
Dependent variable b 95% CI p value b 95% CI p value
Minimal lumen area, mm2 0.001 -0.001 to 0.002 0.30 -0.003 -0.007 to 0.001 0.13
Mean lumen area, mm2 0.001 -0.000 to 0.002 0.14 -0.003 -0.007 to 0.001 0.16
Mean necrotic core arc, (°) 0.089 0.064-0.113 <0.001 0.290 0.207-0.372 <0.001
Max necrotic core arc, (°) 0.139 0.097-0.179 <0.001 0.469 0.339-0.600 <0.001
RNCI, % 0.027 0.021-0.033 <0.001 0.063 0.043-0.084 <0.001
Mean calcium arc, (°) 0.097 0.027-0.167 0.008 0.233 0.045-0.420 0.016
Max calcium arc, (°) 0.063 -0.031 to 0.157 0.19 0.164 -0.089 to 0.419 0.20
RCI, % 0.002 -0.000 to 0.004 0.089 0.004 -0.003 to 0.011 0.27
Minimum cap thickness, μm -0.157 -0.215 to -0.099 <0.001 -2.44 -0.428 to -0.061 0.009
Average cap thickness, μm -0.160 -0.221 to -0.099 <0.001 -0.351 -0.543 to -0.160 <0.001
Values express estimates for increase in the dependent variable per unit increase of IPA6 and IPA11, respectively. P-values derived from 
mixed model regression. Abbreviations: CI, confidence intervals; RNCI, relative necrotic core index; RCI, relative calcium index.
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Figure 7.3 | Example of clinically-evident non-culprit lesion progression. I) Angiogram of LAD in a person 
presenting with new anginal symptoms 20 months after PCI of the LCx for unstable angina. II) Cross-sectional 
OCT images showing progressive narrowing at the region of a fibroatheroma distally (D). At the mid segment 
presence of two plaque rupture sites at baseline, and development of a third plaque rupture site at follow-up (B-
C). A proximal fibroatheroma with regression of necrotic core at follow-up in comparison with baseline (A). III) 
Attenuation spread-out maps showing the longitudinal distribution of maximum attenuation coefficient values 
along the entire segment at baseline and follow-up. One site proximally had reduction (blue arrow), and two 
sites mid and distally increase (red arrow). IV) Plaque spread-out maps with color-coded tissues demonstrating 
reduction of the necrotic core proximally (blue circles), a new rupture at the mid segment and increase of the 
necrotic core distally (red circles). V) Three-dimensional longitudinal cut-away views of the same segment 
demonstrating the above-mentioned changes in plaque morphology (QAngioOCT 3D, Medis Specials bv, Leiden, 
NL). Abbreviations: Ca, calcium; NC, necrotic core; Cav, cavity; asterisk, macrophages; cross, cholesterol crystals.
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7.3.4 | Clinically relevant changes in plaque morphology
There was only one patient with a new clinical syndrome attributed to lesion progression of the imaged 
segment (Figure 7.3). This patient that had been treated with stent implantation in the RCA due to 
NSTEMI, presented with stable angina 20 months later due to progression of a moderate mid LAD 
lesion. Intravascular imaging revealed progressive lumen narrowing in a lesion with fibroatheroma 
morphology, located distally to a segment with several sites of plaque rupture. Interestingly, in the same 
patient there was regression of a proximal lesion with reduction of the necrotic core size and lumen 
expansion. 
7.4 | Discussion
In the current study, we performed comprehensive patient-level and segment-level OCT analyses of 
non-culprit plaque morphology, in order to evaluate the dynamic changes of coronary atherosclerosis 
under standard medical treatment. Quantitative attenuation analysis was used to corroborate findings 
from traditional plaque characterization. Our main findings were that in patients with coronary artery 
disease: 1) change in non-culprit plaque morphology over time occurs frequently, namely in 42% of 
patients and 31% of segments; 2) there are large differences between individual patients and segments with 
some demonstrating plaque stabilization and others plaque destabilization; 3) this effect is hidden when 
globally assessed in the entire cohort, with the exception of cap thickness where a modest thickening is 
observed; 4) these changes are rarely accompanied by clinical manifestations; and 5) prediction of these 
changes from clinical factors and based on their initial morphology is poor.
7.4.1 | Changes of non-culprit plaque morphology over time
Although pathologic studies have demonstrated a pivotal role for plaque morphology in ACS pathogenesis 
[1,2], the processes underlying changes in plaque morphology in vivo are poorly understood. A previous 
OCT study with single frame analysis of plaque morphology has demonstrated lesion progression 
and regression over 12 months at a similar incidence of around 30%, with no significant change in 
around 40% of the lesions. Interestingly, plaque stabilization with reduction of TCFA incidence was 
observed regardless of the changes in luminal dimensions [15]. In our study, at a median follow-up of 6 
months in patients under standard medical therapy, 42% of patients and 31% of the non-culprit native 
atherosclerotic segments had a change of the plaque phenotype. Notably, despite a higher increase in 
necrotic core content and decrease in cap thickness, plaque morphology changed only in a minority 
of fibrous plaques, while TCFAs and fibroatheromas often had dynamic changes in morphology. 
This finding suggests that fibrous plaques should be regarded as relatively stable plaque types with 
low potential for destabilization in a short time period, while fibroatheromas and TCFAs are plaque 
morphologies prone to dynamic changes including both stabilization and destabilization within short 
time frame. Consequently, both plaque types could potentially progress to a culprit lesion over time, an 
observation supported by the finding of plaque rupture also in fibroatheromas with thicker caps [16,17].
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7.4.2 | Change in fibrous cap thickness
Fibrous cap thickness is a major determinant of plaque vulnerability2. In our study, on a segment level, 
minimum and average cap thickness increased from baseline to follow-up (120.4±75.4 μm versus 
134.4±80.8 μm, p=0.019 and 183.5±80 μm versus 206±82.9 μm, p=0.002, respectively). Increase in cap 
thickness has been demonstrated after administration of statins, and is considered to be associated with 
plaque stabilization [18]. This observation is further supported by a higher increase in cap thickness in 
patients receiving more intensive statin therapy [10]. These observations are in line with our findings, 
considering that most patients were being treated with statins, in the context of current recommendations 
for cardiovascular risk reduction in patients with coronary disease. Yet, despite this increase in cap 
thickness in the overall cohort, a non-negligible percentage of segments (21%) presented with fibrous 
cap thinning. This suggests that although statin treatment might promote plaque stabilization on a 
population level, this effect is not observed in all patients and in the entire coronary tree, with individual 
observations of cap thinning despite intensive systematic therapy. Thus, although medical therapy can 
promote plaque stabilization, this effect is not universal. This might call for additional or alternative 
(eventually local) therapeutic concepts and a tailored approach [13].
7.4.3 | Clinical relevance of the observed changes
Previous studies have demonstrated an association of non-culprit plaque morphology by intravascular 
ultrasound with virtual histology (VH-IVUS) with future adverse coronary events [3-5]. Yet, this 
association was only modest, considering the low incidence of adverse events, and a high prevalence of 
VH-TCFA (40-60%) and could in large part be explained by limitations of VH-IVUS in the detection 
of necrotic core and thin fibrous cap [19,20]. Our study underscores another important limitation of 
intracoronary imaging in identifying high-risk plaques. Even with high-resolution imaging, such as 
OCT, that can more accurately identify plaques with high-risk morphology [20], plaque morphology on 
its own has a poor predictive ability as it is subject to dynamic changes. These morphological changes 
can occur in the absence of clinical manifestations, while even our observation of clinically relevant 
progression due to progressive luminal narrowing in a setting of highly inflamed coronaries and non-
culprit plaque ruptures, was seen in conjunction with plaque regression in another segment of the same 
patient, supporting the hypothesis that morphological plaque changes are highly localized and are 
observed on individual plaque level rather than on patient level.
Moreover, these changes in plaque morphology, were poorly predicted by patient-level or lesion-level 
factors. This finding implies a limited ability to predict lesion behavior. A possible explanation for this 
currently unpredictable behavior might be the effect of local hemodynamics on plaque morphology, 
as the presence of low wall shear stress has been associated with reduction of luminal dimensions and 
development of high-risk plaque morphology [5,21].
7.4.4 | Automated plaque characterization
For the objective documentation of plaque morphology, we used automated attenuation analysis. 
Increased attenuation has been associated with high-risk plaque characteristics such as necrotic 
core and macrophages [12]. The results of this analysis were in line with conventional OCT plaque 
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characterization showing increasing values of attenuation indexes from fibrous to fibroatheroma to 
TCFA, corroborating our analysis. Furthermore, the observations of strong correlations of these indexes 
with increased necrotic core content and reduced cap thickness suggest that such an analysis could be 
employed for monitoring changes in plaque morphology over time.
7.4.5 | Future perspectives
Our findings add to the current understanding of progression of non-culprit segment atherosclerosis 
in vivo under standard medical therapy. The finding of dynamic changes occurring even in different 
segments of the same patient underscores limitations of current imaging methods in detection of high-
risk plaques [20], and a need for identification of additional markers of plaque instability. Consequently, 
the combined assessment of plaque morphology with local hemodynamics, or plaque morphology with 
local biochemical activity might be able to better identify plaques prone to progression [22,23]. Further, 
identification of additional morphological factors associated with plaque instability, such as assessment 
of the collagen content or fibrous cap microcalcifications might provide a better discrimination of high-
risk plaques [24].
7.4.6 | Limitations
This is a small retrospective single-center registry investigating the changes in plaque morphology in 
non-culprit segments in patients under standard medical treatment. As such, our study is prone to the 
limitations of all retrospective, non-randomized studies. In order to account for the small sample a 
comprehensive analysis of plaque morphology was performed and further corroborated by quantitative 
attenuation analysis. Furthermore, the use of meticulously matched sub-segments allowed us to study 
changes of plaque morphology in a large number of segments and detect within-patient differences, not 
easy to detect with a patient-level analysis. Moreover, the absence of a pre-specified medical regimen 
does not allow generalization of our findings in specific populations. Finally, due to the limited patient 
sample and short follow-up, our study was clearly underpowered for identifying an association between 
changes in morphology and clinical events.
7.5 | Conclusions
In non-culprit coronary segments of patients with coronary artery disease under standard medical 
therapy, there is an increase in fibrous cap thickness over time. However, high differences are observed 
between individual segments with some segments demonstrating plaque stabilization and others plaque 
destabilization. None of the clinical factors could predict these changes possibly implying a need for 
reconsideration of current hypotheses and adaptation of future study designs.
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Abstract
Purpose: The aim of this study was to investigate the relationship between the plaque free wall 
(PFW) measured by optical coherence tomography (OCT) and the plaque burden (PB) measured by 
intravascular ultrasound (IVUS). We hypothesize that measurement of the PFW could potentially 
help to estimate the PB, thereby overcoming the limited ability of OCT to visualize the external elastic 
membrane in the presence of plaque. This could enable selection of the optimal stent-landing zone by 
OCT, which is traditionally defined by IVUS as a region with a PB<40%.
Methods: PB (IVUS) and PFW angle (OCT and IVUS) were measured in 18 matched IVUS and OCT 
pullbacks acquired in the same coronary artery. We determined the relationship between OCT measured 
PFW (PFWOCT) and IVUS PB (PBIVUS) by non-linear regression analysis. An ROC-curve analysis was 
used to determine the optimal cut-off value. Sensitivity, specificity, positive predictive value (PPV) and 
negative predictive value (NPV) were calculated for the detection of PB<40%.
Results: There is a significant correlation between PFWOCT and PBIVUS (r2=0.59). The optimal cut-off 
value of the PFWOCT for the prediction of a PBIVUS<40% is ≥220° with a specificity of 78% and an NPV 
of 88%. 
Conclusion: This study shows that PFWOCT can be considered as a surrogate marker for PBIVUS, which is 
currently a common criterion to determine optimal stent-landing zone. 
Keywords: Optical coherence tomography, intravascular ultrasound, plaque free wall, plaque burden, 
stent-landing zone
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8.1 | Introduction
In recent years, intravascular optical coherence tomography (OCT) has emerged as imaging technique for 
guiding percutaneous coronary intervention (PCI). OCT offers a very high spatial and lateral resolution 
compared to intravascular ultrasound (IVUS). However, this comes at the expense of penetration 
depth into the tissue [1]. Based on IVUS studies, the plaque burden (PB) is a leading criterion for a 
stent-landing zone, where areas with PB<40% [2] p<0.001 are considered optima. The ability of OCT to 
visualize plaque burden is limited by optical attenuation: the signal decrease with depth in tissue. Either 
a thick layer of fibrous (low-attenuation) plaque or the presence of superficial (high-attenuation) lipids 
or dense macrophage accumulations [3], may obscure the visibility of the media behind the plaque. 
This potentially limits the use of OCT to guide stent implantation when it comes to the selection of the 
optimal stent landing zones within the target artery. More recently, the absence of lipid/necrotic core 
within the landing zone has been advocated in addition to low plaque burden [4], a criterion which can 
be very well identified by OCT, in contrast to IVUS.
In a previous study [5] we tested the hypothesis that plaque free wall (PFW, we demonstrated a strong 
inverse linear relationship between PB and the plaque free wall (PFW) angle using IVUS imaging (PBIVUS 
and PFWIVUS). In the present study we hypothesize that the angle of the PFW measured in OCT (PFWOCT) 
can likewise reflect the PB. Second, we postulate that regions with a PB<40% can be selected for finding 
an optimal stent-landing zone. When the PFW angle is small (<180°), it might be instantly clear that 
disease is present with a PB>40%, thus forming a suboptimal stent-landing zone. Similarly, sections with 
a large PFW angle >270° can be easily and reliably identified by OCT as optimal stent-landing zones 
with a PB<40%. However, in the intermediate region between 180°-270° PFW, the interpretation might 
be more ambiguous. The aim of this study was to investigate the relationship between PFWOCT and 
IVUSPB and establish the utility (expressed in predictive values for PB<40%) of this relationship to detect 
PB<40% for selection of the optimal stent landing zone by OCT. 
8.2 | Materials and Methods
8.2.1 | Study population 
To study the predictive value of the OCTPFW for determination of the PB, we performed a retrospective 
observational study. NIRS-IVUS (TVC, InfraRedx, Burlington, Massachusetts, USA) and OCT (St. Jude 
Medical Inc., St. Paul, MN, USA) pullbacks of the same ROI were used from 18 left anterior descending 
(LAD) coronary arteries of 18 patients with stable or unstable coronary syndrome included in the OC3T 
study (Erasmus MC, Rotterdam). 
The NIRS-IVUS images were acquired using a commercially available hybrid optical/ultrasound catheter 
with an automated pullback (pullback speed 0.5 mm/sec and 16 frames per second). The OCT images 
were obtained with C7-XR/Illumien and Dragonfly catheter. Automated OCT pullback (pullback speed 
20 mm/s) was performed during simultaneous iso-osmolar X-ray contrast medium (Visipaque 320, 
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GE Healthcare, Buckinghamshire, U.K.) delivery through the guide catheter, using a power injector 
(Medrad ProVis, Bayer HealthCare LLC, NJ, U.S.A; typical flush rate 3.0 ml/s).
8.2.3 | Analysis
The OCT and IVUS pullbacks were matched by overlaying the frames with same side branches. The 
remainder of the frames was linearly interpolated in between the side branches. Matched NIRS-IVUS 
and OCT images were analyzed every millimeter over a ROI of the most proximal 20 mm of a pullback. 
On the IVUS images, the external elastic lamina (vessel area=VA) and lumen area (LA) contours were 
drawn using QCU-CMS software (version 4.69, Leiden University Medical Centre, LKEB, Division of 
Image Processing). These contours were used for the calculation of the plaque area (PA=VA-LA) and 
subsequently the PB (PA/VA*100%). PFW angle was defined from the center of the lumen as the arc of 
the cross-section with a visible, healthy wall having an intima-media thickness of less than 0.5 mm in 
both imaging modalities. In total, 360 frames were analyzed on both the IVUS and OCT images. The 
frame data were averaged over 3 mm sections to increase robustness and to compensate for imprecise 
matching. Images that showed a side branch either on IVUS or OCT, with the wall out of view or a bad 
flush were excluded. This resulted in 106 matched IVUS and OCT 3mm sections suitable for analysis. A 
total of 10 out of the 18 pullbacks of OCT and IVUS were analyzed by two independent expert observers 
for assessment of the reproducibility. 
8.2.4 | Statistics
Statistical analysis was performed using SPSS software (version 21.0, SPSS Inc., Chicago, IL, USA). 
Findings were regarded significant when p<0.05. The reproducibility of all PFW and PB measurements 
was assessed by performing an inter-observer agreement analysis to calculate the intraclass correlation 
coefficient. 
Both a linear and a non-linear model were used to assess the relation between PFWIVUS/OCT and PBIVUS. 
The non-linear model was defined as follows: 
   
  
PBIVUS=  a × PFW + b       for PFW ≤
PBIVUS=  d × PFW + e      for >
(e–b)
(a–d)
(e–b)
(a–d)
 
 
computed for both PFWOCT and PFWIVUS. For the non-linear regression analysis, the following starting 
parameters were chosen: a=0; b=55; d=-0.2; e=100. We denote the crossover value between both linear 
regimes as PFWC=(e-b)/(a-d), resulting from the regression.
To test whether the slope of the relationship between PFWOCT vs PBIVUS and PFWIVUS vs PBIVUS was 
similar, implying that with PFWOCT and PFWIVUS the same PB is predicted, a student’s t-test for two 
independent samples was used. An ROC-curve analysis was performed to find the optimal cut-off 
value of PFWOCT to predict a PBIVUS<40%. Based on the optimal cut-off value, the sensitivity, specificity, 
positive predictive value (PPV) and negative predictive value (NPV) of PFWOCT for prediction of PBIVUS 
<40% were calculated. 
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8.3 | Results
8.3.1 | Relation between PFW and PB in IVUS
PFWIVUS and PBIVUS were significantly, inversely related (r2=0.78) which confirmed the findings of our 
previous publication [5] we tested the hypothesis that plaque free wall (PFW. However, a closer fit to 
the model was found by applying a non-linear regression line (r2 =0.82) (Figure 8.1a), with PFWC=183°. 
Figure 7.1 | Relationship between the plaque free wall (PFW) angle and plaque burden (PB). A) The PFWIVUS 
measured shows a strong inverse, non-linear correlation with the IVUS PB with a breakpoint at 183° PFW. B) A 
similar relationship is seen for the OCT PFW angle and the IVUS PB with a breakpoint at 186° PFW. C) Overlay 
of regression lines of A) and B). PFWOCT and PFWIVUS perform equally well in predicting PB in the region of 
PFW angle >186°. In the more diseased regions, the predictive value of the OCT PFW angle is reduced compared 
to IVUS.
8.3.2 | Predictive value of PFWOCT
To assess whether the PFWOCT could serve as a surrogate marker for PBIVUS, the PFWOCT values were 
plotted against the PBIVUS values. Again, a non-linear regression relationship proved significant (r2=0.59) 
(Figure 8.1b) with PFWC=186°. Interestingly, both IVUS and OCT show the same slope (student’s t-test 
for inequality of slopes; p=NS) to predict PB for PFW ≥ 186⁰. For PFW<186⁰, PFWOCT had no clear 
relationship with the PB, contrasting the PFWIVUS which still showed a weak relationship with the PB 
(Figure 8.1c). 
To find the optimal cut-off value of the PFWOCT to predict a PBIVUS <40%, an ROC-curve analysis was 
performed. Optimization of sensitivity, specificity, PPV and NPV resulted in a PFWOCT cut-off value of 
≥220⁰ (Figure 8.2). With this cut-off value, an optimal stent-landing zone (PB<40%) could be predicted 
correctly in 78% of the cases (PPV) (Figure 8.3). Just as important, the NPV was 88%, meaning that 
if the PFW angle is <220⁰, PB >40% and thus forming a suboptimal stent-landing zone in 88% of the 
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cases. This high negative predictive value will largely prevent stenting too far into a health vessel region 
(PB<40%).
Figure 7.2 | Clinical application of PFW angle detection. When a PFW of ≥220° is seen on OCT, in 78% of the 
cases this indicates the presence of a PB<40% and thus an optimal stent landing zone.
As an angle of 220 degrees might be difficult to judge by simple eyeballing in the cathlab, we investigated 
the predictive value of 180 degrees for PB<40% ad thus a suitable stent-landing zone. Despite the strong 
relationship between PFWOCT and PBIVUS, regions with a PFW angle >180° can be regarded as an optimal 
stent landing zone with a PB<40% in only 57% of the cases. So strikingly, in 43% of the cases the disease 
is more severe with a PB>40%, even with only half of the circumference being occupied by plaque.
8.3.3 | Reproducibility 
Inter-observer agreement analyses of the PFW measurements were performed in 189 OCT and 177 IVUS 
frames and showed high intraclass correlation coefficients of respectively 0.956 (95% CI: 0.941-0.967) 
and 0.912 (95% CI: 0.884-0.934). The intraclass correlation coefficient of the PBIVUS measurements was 
equally high at 0.886 (95% CI: 0.847-0.915).
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8.4 | Discussion
This study shows for the first time that PFWOCT can be considered as a surrogate marker for PB, which 
is currently a common criterion to determine stent-landing zone. In regions with a PFW angle >186⁰, 
the PFWOCT has the same predictive value compared to PFWIVUS. The optimized cut-off value to predict 
optimal stent landing zone (PB<40%) is ≥220⁰ PFWOCT. A cut-off value of 180⁰ PFWOCT is not sufficiently 
specific for PB <40%, even though it is easier to apply in clinical routine.
There is a precarious balance between adequate lesion coverage and using too long stents. The first 
strategy poses a risk on plaque disruption and edge dissections when the edge of the stent lands in a 
plaque area. On the other hand, placing longer stents might prove technically more challenging and 
might increase the risk on in-stent restenosis and stent thrombosis, even in drug eluting stents [6]. For 
this reason, determining an optimal stent-landing zone is critical for the prevention of future stent-
related adverse events. 
An optimal stent-landing zone is a region without lipids and a PB<40%. In contrast to IVUS, OCT is 
capable of detecting lipids, but the limited penetration depth hampers PB measurements. OCT can 
reliably detect the healthy vessel wall, however. Therefore, we wanted to investigate if the presence of a 
normal wall is helpful to predict PB by OCT. This study showed that a measurement of the PFW angle 
provides a reliable estimate of the PB, without the need to fully visualize the outer wall of the vessel and 
together with the fact that OCT is one of the most reliable techniques to structurally asses the presence 
of a vulnerable plaque [7,8]. 
The detection of the PFW in OCT can be influenced by the composition of the intima. Plaque components 
like a lipid/necrotic core and sites of inflammatory activity cause high attenuation and may obscure the 
vessel wall layers, even in a relatively thin intima. Plaque-free regions (IMT<0.5mm) with a superficial 
layer of macrophages or foam cells (intimal xanthoma) can appear as regions with plaque, since the 
healthy 3-layered structure of the vessel is not visible. This leads to underestimation of the PFW angle 
and thus overestimation of the plaque burden. The confounding effect of vessel wall composition may 
explain why the association between PFWOCT and PB almost vanishes in the more diseased sections. 
We observe a similar trend in the relation between PFWIVUS and PB, although the detection of the PFW 
by IVUS is usually not affected by attenuation-inducing plaque components, indicating a possible 
biological phenomenon. In the initial stages of plaque growth, the asymmetric plaque growth results in 
a simultaneously decreasing PFW angle and increasing PB. Apparently in later stages, the plaque growth 
becomes more symmetrical, decreasing the PFW angle with only a limited increase in PB and thus 
weakening the relationship. This explanation should be supported by serial imaging studies.
PCI procedures are always guided by angiography to determine catheter position and lumen narrowing. 
Currently, it is challenging to identify segments seen on OCT with the corresponding location on 
angiography which could lead to wrong sizing and positioning of the stent. The recently introduced 
on-line co-registration of OCT and angiography [9] it may be challenging to identify corresponding 
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segments between intracoronary imaging and angiography. Computer based online co-registration may 
aid the target segment identification.\n\nMETHODS: The DOCTOR fusion study was a prospective, 
single arm, observational study including patients admitted for elective PCI. Optical coherence 
tomography (OCT could greatly increase the utility of OCT and thereby the application of our findings 
in the clinical work flow. The most predictive cut-off angle of 220° PFW is hard to determine by eye. This 
might limit direct clinical application of our findings. New software for the automatic detection of the 
three wall layers and the determination of the PFW angle is under development in our university.
8.4.1 | Limitations
Some limitations in our study should be taken into account. Despite the use of side branches for optimal 
matching of OCT and IVUS pullbacks, errors in matching can occur due to intrinsic differences between 
the two techniques. These include, amongst others, pull back speed, lateral resolution and frame rate. 
To minimize the impact of these mismatches on the accuracy of the results, the measurements were 
averaged over a region of 3 mm, which is a larger than the maximum expected longitudinal mismatch. 
Furthermore, a number of frames were excluded in the proximal regions of the pullbacks due to bad 
flush or when the vessel wall was out of view. 
Only a limited number of matched pullbacks were available for analysis. Since we analyzed the IVUS 
images per cross-section and not longitudinally, we regarded the 7 data points per pull-back as separate 
observations. However, these results should still be interpreted as being a proof-of-principle study. We 
do not expect that our conclusion would be much different with a larger dataset. 
 
8.5 | Conclusion
In conclusion, this study shows that PFWOCT is a good predictor for the PB and gives more insight in 
the general interpretation of PFWOCT angles. After further clinical validation, this new plaque burden 
estimation based on OCT could help to identify the optimal landing zone.
8.6 | Ethical standards
Informed consent was obtained from each patient and the study protocol conforms to the ethical 
guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the institution’s human 
research committee.
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Supplementary figure
Supplementary figure 8.1 | Sensitivity, specificity, PPV and NPV values for different PFW angle cut-off points to 
predict a PB<40%. The optimal cut-off point is set at 220° PFW.
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Intravascular OCT has demonstrated to be a powerful tool for diagnostic imaging in coronary 
atherosclerosis. Quantification of the OCT images for characterization of the atherosclerotic tissue types 
and validating the method was the scope of this thesis. The attenuation coefficient is one such parameter 
of the OCT signal, which can be quantified and is tissue dependent. Correlation between attenuation 
imaging of OCT and tissue types has been studied previously [1,2]. In this thesis we did ex-vivo and 
in-vivo validation of attenuation imaging as a tissue characterization tool and demonstrated some of its 
clinical research utilities.
En-face attenuation maps
In the second chapter we introduced an analysis method that is robust against common registration 
errors. The OCT pullback has a disadvantage of large frame pitch (200 µm) that can make it difficult to 
find the same cross section accurately represented by a 3 µm thick histology section in a vessel, or to 
register an independent invasive imaging data set to that degree of precision. To overcome this sampling 
problem, we constructed a longitudinal representation of the pullback to make quantitative comparisons 
[3]. This is an improvement over the analysis in cross section images as the map depicts tissue features 
as a whole, along the vessel. This representation also allows for non-rigid registration to correct for non-
uniform rotation and variations in effective pullback speed (due to cardiac motion in vivo). 
The map was constructed by sampling a user specified depth window for the average or maximum value 
of attenuation from the lumen border. The drawback of this longitudinal representation is that it is a 
two-dimensional cross section through a three-dimensional data set, hence sacrifices depth resolution. 
For detailed analyses, several longitudinal maps at different depths from the lumen boundary can be 
extracted.
We studied the effects of temperature and tissue fixation on the optical properties specifically the 
attenuation coefficient of the tissue properties. Ex-vivo validation is an essential step for any new OCT 
analysis methods, it is important to know how common tissue preparation steps affect the parameters 
that can be quantified from the OCT images. We observed very small differences induced by temperature 
and fixation: relative to unfixed tissue at 37°C (close to body temperature conditions) , the attenuation 
coefficient differs by a few percent at most in other conditions.
Index of Plaque attenuation
Based on this en-face attenuation map, we defined an Index of Plaque Attenuation (IPA) in Chapter 3 
to quantify the parametric attenuation image. IPA is the ratio of the number of pixels in the attenuation 
map or a segment of it with an attenuation coefficient greater than a certain threshold x to the total 
number of pixels, multiplied by a factor of 1000.
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We studied the ability of the index of plaque attenuation (IPA), a bias free and reproducible summary 
measurement of attenuating tissue types, as a lipid-core detection tool. The results show that the OCT-
derived index, the IPA8.5, have a significant correlation with the manual lipid score in OCT images, which 
enables automation of the coronary plaque lipid assessment by OCT. Lipid scoring in OCT for clinical 
research is a time consuming process, where frame-by-frame analysis and measurement is required. The 
correlation between IPA8.5 and manual lipid measurements is significantly higher than the correlation 
between the lipid score by OCT to automated indices like the near-infrared spectroscopy (NIRS)-based 
Lipid Core Burden Index (LCBI) [4]. The detection mechanisms of the two modalities and the frame 
spacing might explain the variability between OCT and NIRS.
The IPA has the potential as a clinical tool as it can indicate the presence and location of lipid rich plaques 
in an entire vessel. It is the result of automatic computation of plaque attenuation, hence provides an 
alternative to manual scoring in cardiovascular research. IPA could be displayed as a color-coded block 
along the vessel indicating probable lipid core. IPA, being an index calculated from a physical parameter, 
is robust and reproducible.
The study also showed that the thick cap fibroatheroma usually contains variable amount of lipid content 
that can contribute to attenuation among other components. Hence varying range of IPA values were 
observed for them. On the contrary the thin cap fibroatheroma which is also typically characterized by 
dense macrophage infiltration exhibited high IPA. Also the pathological intimal thickenings (PITs) with 
macrophage exhibited high IPA values even though pathological evidence of lipid was not available. The 
gap between the PITs with and without macrophages was very significant. PITs without macrophages or 
lipid droplets and fibrotic plaques had almost zero value for IPA.
Clinical study
In Chapter 4, a study is described that aimed to validate optical attenuation as a plaque characterization 
tool in vivo. The main finding of the single-center clinical study was that the fraction of image pixels 
with optical attenuation greater than 11 mm-1 (IPA11), can reliably differentiate between thin and thick 
cap fibroatheroma and is superior compared to LCBI for making this distinction. This discrimination is 
facilitated by deeper-lying lipids that exhibit reduced attenuation in OCT images. The limited specificity 
of optical attenuation in overall lipid detection results in a modest correlation between IPA and LCBI. 
Fibrocalcific plaques in the dataset also had higher IPA and LCBI values suggesting the presence of lipid. 
The IPA values of TCFA are significantly higher than the fibrocalcific plaques.
The ability of the automatically computed attenuation coefficient to highlight the presence of TCFA 
in a complete pullback makes it a tool with potential clinical utility. After appropriate validation, IPA 
analysis may replace the time-consuming and laborious manual measurements. OCT-derived IPA11 may 
be a feasible method to detect LCP with a thin cap, an important indicator for plaque instability [5]. In a 
clinical application, realistic implementation would include automatic media segmentation, after which 
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the attenuation analysis can be overlaid on the OCT images. The en-face map display and colour coded 
IPA11 displayed on the longitudinal section (similar to the block chemogram used in NIRS), would 
enable direct overall assessment of plaque in the artery to guide revascularization procedures. 
Comparison of tissue characterization methods
In chapter 5 we qualitatively compared some of the available methods for OCT tissue characterization. 
Algorithmic OCT tissue type characterization can provide a valuable metric for automated assessment 
of the extent and severity of atherosclerotic coronary artery disease. The different methodologies were 
performed on a set of ex-vivo data and compared with the histological annotations by skilled pathologists. 
Each of the methods of OCT tissue characterization compared, has value as an atherosclerotic tissue 
component detection tool and could play a significant role in the assessment of the stability of the plaque.
The first few sections of the thesis described the validation of the tissue characterization method using 
optical attenuation ex and in-vivo. The next few sections show its potential as a clinical research tool in 
stent follow up and plaque progression studies.
Biovascular scaffold follow-up study
In Chapter 6 we present the first in-vivo long-term OCT data 5 years after BVS implantation. The study 
included some of the first patients treated with BVS, offering a unique opportunity to study the long-
term vascular response after BVS implantation despite small size. Our main findings are that there is 
late lumen enlargement and all struts have disappeared and been integrated within the neointima. The 
underlying plaque formed a signal-rich, low-attenuating ‘sealing layer’, while in one exceptional case, 
thinning and disruption of the ‘sealing layer’ was observed. Metal drug eluting stents in the same vessels 
are lacking a distinct ‘sealing layer’ and show neoatherosclerosis despite good coverage and apposition. 
 
We observed a consistent luminal enlargement and a recovery of the luminal symmetry from 2 to 5 
years in all patients. Our hypothesis is that simultaneous observations of strut bioresorption and ‘sealing 
layer’ development suggest a potentially favourable biological effect. Based on the suggestion that BVS 
implantation could induce morphological changes causing a ‘plaque sealing’ or ‘recapping the plaque’ 
we scrutinized the BVS morphology in our cohort, employing sophisticated algorithms for in-depth 
analysis.
We focused on the newly formed adluminal signal-rich layer, which we defined as ‘sealing layer’, which 
could reliably protect the lumen from thrombogenic plaque components. In attenuation analysis 
the ‘sealing layer’ appears homogeneous with low attenuation, suggesting absence of high-risk wall 
components such as necrotic core and macrophages [1,6]. Therefore we assume that the sealing layer 
can be protective against very late scaffold thrombosis or de novo thrombosis by plaque progression and 
rupture [7,8]. 
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The complete scaffold integration into the vascular wall has shaped a ‘neo-plaque’ phenotype which 
we visually characterized using standardized OCT criteria [9]. Quantitative attenuation analysis also 
depicts these necrotic core regions with high attenuation. High attenuation regions were generally 
located deeper into the vessel wall. In contrast, metal drug-eluting stents in our cohort showed marked 
adluminal neoatherosclerosis, with significantly thinner cap.
Plaque progression
In Chapter 7, we performed comprehensive patient-level and segment-level OCT analyses of non-
culprit plaque morphology in order to evaluate the dynamic changes of coronary atherosclerosis under 
standard medical therapy. We also performed quantitative attenuation analysis in order to corroborate 
findings from plaque characterization. In patients with coronary artery disease under standard medical 
therapy, plaque morphology changes over time in a high percentage of cases. High differences between 
individual patients and segments were observed with some demonstrating plaque stabilization and 
others plaque destabilization rather than significant entire cohort differences. Even in the cohort, modest 
thickening was observed. These changes are rarely accompanied by clinical manifestations. Prediction of 
these changes from clinical factors and based on their initial morphology is poor.
For short follow-up intervals, fibrous plaques are relatively stable plaque types while fibroatheromas and 
TCFAs are prone to dynamic changes including both lesion stabilization and destabilization. Over time, 
both plaque types could potentially progress to a culprit lesion, an observation supported by the finding 
of plaque rupture also in fibroatheromas with thicker caps [10,11].
Fibrous cap thickness is a major determinant of plaque vulnerability [8]. In our study, on a segment 
level, minimum and average cap thickness increased from baseline to follow-up but a non-negligible 
percentage of segments were presented with fibrous cap thinning. This suggests medical therapy can 
promote plaque stabilization but this effect is not universal, and local therapies could be considered[12]. 
Our study also suggests morphological plaque changes are highly localized and are observed on 
individual plaque level rather than on patient level.
We used automated attenuation analysis to study objectively the plaque morphology. High attenuation 
has been associated with high-risk plaque characteristics such as necrotic core and macrophages [1]. 
The results of this analysis were in line with traditional OCT plaque characterization showing increasing 
values of attenuation indexes from fibrous to fibroatheroma to TCFA. Furthermore, the observations 
of strong correlations of these indexes with increased necrotic core content and reduced cap thickness 
suggest that an automated analysis could be employed for monitoring of the dynamic changes in plaque 
morphology.
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Registration of OCT and IVUS
In Chapter 8 we studied the relationship between the plaque free wall (PFW) measured in OCT and the 
plaque burden (PB) measured in the IVUS. This study shows for the first time that PFW angle in OCT 
can be considered as a surrogate marker for PB, which is currently a common criterion to determine 
stent-landing zone. The registration of IVUS and OCT was an essential part of the comparison. An 
in-house registration tool with GUI was developed where physical landmarks like the side branches in 
the vessel pullbacks from both modalities can be selected and used as control points for registration. 
Plaque burden and plaque free wall measurements in IVUS are quite common but the detection of the 
PFW in OCT can be influenced by the presence of plaque components like calcium, macrophages and 
a lipid/necrotic core, which cause high attenuation. Even a thin layer of highly attenuating macrophage 
infiltration or lipids can appear similar to an unstable plaque due to the absence of the layered structure 
of the vessel. This could lead to underestimation of the PFW angle and thus overestimation of the plaque 
burden. This could explain why the relationship between PFWOCT and PB is very limited in the more 
diseased sections. The results show that this attenuation effect would not influence the prediction of an 
optimal stent-landing zone. 
One of the downside of the OCT is the penetration depth especially in plaque rich region, which makes 
it a difficult candidate for PB measurements. We showed that, by looking at the PFW angle, a reliable 
estimation can be made of the plaque burden without the need to fully visualize the outer wall of the 
vessel. Apart from the plaque burden, the plaque characteristics play a major role determining stent-
landing zone. OCT is currently one of the most reliable techniques to structurally assess the presence of a 
vulnerable plaque [13] which adds to the reliability and applicability of this technique in PCI procedures. 
Outlook
The en-face attenuation maps and IPA, which are the results of automatic computation of plaque 
attenuation, have the potential as clinical tools as they can indicate the presence and location of lipid rich 
plaques in an entire pullback, and provides an alternative to manual scoring in cardiovascular research. 
IPA could be displayed as a color-coded block along the vessel indicating probable lipid core plaques. 
The utility of such a tool would need to be evaluated in a dedicated study enrolling a larger group of 
patients. Also extensive ex-vivo studies are needed to establish the correlation of attenuation with more 
tissue types. Application to large data sets will be facilitated by automated media segmentation, a tool 
that is currently being developed in our institute [14]. 
The BVS follow-up study depicted a very good correlation between the manually segmented plaques 
and the plaques identified by attenuation maps adding strength to its potential clinical utility. The study 
was conducted in the first few BVS implanted patients and was a single centered. A more detailed and 
dedicated follow-up study is needed to evaluate the hypothesis developed from this limited scope study.
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In our study of the progression of non-culprit segment atherosclerosis, a comprehensive analysis of 
plaque morphology was performed and further corroborated by quantitative attenuation analysis. This 
required matching of sub-segments in baseline and follow-up OCT pullbacks. The frame spacing of the 
commercial OCTs are relatively high which makes the matching very difficult. Currently a very high 
speed and high resolution OCT is being developed in our institute that has a very significantly low 
frame spacing. Attenuation analysis on the pullbacks of the OCT system can result in a more accurately 
matched dataset. 
PCI procedures are always done with angiographical guidance to determine catheter position and lumen 
narrowing. Registering OCT data to angiography is a challenging task, which could lead to wrong sizing 
and positioning of the stent. The recently developed co-registration software for OCT and angiography 
[9] it may be challenging to identify corresponding segments between intracoronary imaging and 
angiography. Computer based online co-registration may aid the target segment identification.\n\
nMETHODS: The DOCTOR fusion study was a prospective, single arm, observational study including 
patients admitted for elective PCI. Optical coherence tomography (OCT could greatly reduce this risk 
and increases the utility of our findings.
Moreover, manually measuring the cut-off value of 220° PFW is hard, which limits the direct clinical 
application. New software for the automatic detection of the three wall layers and the determination of 
the PFW angle is under development in our university [14]. This software would greatly increase the 
clinical value of our findings. 
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Summary
Intravascular OCT is a popular tool for PCI guidance and diagnostic imaging. Atherosclerosis is a 
progressive disease of the arterial wall and the sudden rupture of an unstable lipid rich plaque causes 
acute myocardial infarction. The tissue composition of the atherosclerotic plaque is a major factor for 
its instability. Quantification of optical parameters in OCT images can be a tool for atherosclerotic 
tissue characterization. The attenuation coefficient, a tissue dependent parameter of the OCT has been 
demonstrated to have good correlation with tissue types.
Within the scope of this thesis we did ex and in-vio validation of attenuation imaging as a tissue 
characterization tool and demonstrated some of its clinical research utilities.
In Chapter 2 we studied the effect of temperature and fixation on the attenuation coefficient of tissue 
properties. We compared the en-face attenuation maps at different conditions. The results show that 
the tissue fixation and temperature do not systematically affect the optical attenuation properties of the 
tissues.
Chapter 3 is an ex-vivo study where we introduced an index of plaque attenuation (IPA) based on the 
en-face attenuation maps. We studied the potential of IPA as a lipid detection tool. The results show that 
the IPA has a correlation with manual lipid scores and hence has the potential to adequately replace 
laborious and time-consuming manual measurements.
In Chapter 4 we describe a clinical study that aimed to validate attenuation imaging as a plaque 
characterization tool in vivo. The study showed that IPA can significantly differentiate thin and thick 
cap fibroatheroma.
In Chapter 5 we qualitatively compared some of the available methods for OCT tissue characterization. 
The algorithms were used to analyze an ex-vivo data set and compared with the histological tissue 
type characterization. The methods included in this study all have assets that make them valuable 
contributions to the image analysis toolbox in clinical OCT imaging.
In Chapter 6 we present the first in-vivo long-term OCT data 5 years after BVS implantation. The 
attenuation maps and IPA prove to be potential clinical research tools depicting plaque ‘passivation’, 
including the formation of a potentially protective ‘sealing layer’ in the long-term BVS follow-up.
In Chapter 7, we performed comprehensive patient-level and segment-level OCT analyses of non-
culprit plaque morphology in order to evaluate the dynamic changes of coronary atherosclerosis under 
standard medical therapy. We also performed quantitative attenuation analysis in order to corroborate 
findings from plaque characterization. The study show a good relation between plaque changes and 
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tissue type identified by attenuation. IPA is not an independent predictor but is correlated with plaque 
type, which does relate to change. 
We studied the relationship between the plaque free wall (PFW) measured in OCT and the plaque 
burden (PB) measured in the IVUS in Chapter 8. OCT measured PFW angle is a good predictor for the 
PB and hence increasing the feasibility to use an OCT catheter only, instead of the combination with 
IVUS during a stenting procedure, reducing patient risk, procedure length and costs. 
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Samenvatting
Intravasculaire OCT is een populair hulpmiddel tijdens het sturen van PCI’s en voor diagnostische 
beeldvorming. Atherosclerose is een progressieve ziekte van de vaatwand en het plotseling scheuren 
van een onstabiele lipide-rijke plaque veroorzaakt myocardiale infarcering. De weefselsamenstelling 
van de atherosclerotische plaque is een grote factor voor zijn instabiliteit. Het kwantificeren van 
optische parameters in OCT-beelden kan een methode zijn voor atherosclerotische plaque typering. De 
verzwakkingscoëfficiënt, een weefselafhankelijke parameter van OCT, is een bewezen goede afspiegeling 
van weefsel types.
Binnen het kader van deze thesis hebben we ex- en in-vivo validatie van verzwakkingsbeeldvorming als 
een weefseltyperingsmethode uitgevoerd en hebben enkele klinische toepassingen aangetoond.
In hoofdstuk 2 hebben we het effect van temperatuur en fixatie op de verzwakkingscoëfficiënt van 
weefseleigenschappen bestudeerd. We vergeleken de ‘en-face’ verzwakkingskaarten onder verschillende 
omstandigheden. De resultaten laten zien dat weefselfixatie en temperatuur geen systematische invloed 
hebben op de optische verzwakkingseigenschappen van weefsel.
Hoofdstuk 3 is een ex-vivo studie waar we een index van plaque verzwakking (IPA) gebaseerd op ‘en-
face’ verzwakkingskaarten hebben geïntroduceerd. We bestuurden de potentie van IPA als een lipiden 
detectiemethode. De resultaten laten zien dat de IPA een correlatie heeft met handmatig uitgevoerde 
lipide scores en dus de potentie heeft om intensieve en tijdrovende handmatige metingen te vervangen.
In hoofdstuk 4 beschrijven we een klinische studie die beoogde om verzwakkingsbeeldvorming 
als plaque typering in-vivo te valideren. De studie laat zien dat IPA op een significante manier kan 
differentiëren tussen een dunne en dikke kap fibroatheroom.
In hoofdstuk 5 hebben we op kwalitatieve manier de beschikbare methodes van OCT-weefseltypering 
vergeleken. De algoritmen werden gebruikt om ex-vivo data te analyseren en werden vergeleken met 
histologische weefseltypering. De getoetste methodes in deze studie hebben allemaal eigenschappen die 
waardevolle toevoegingen kunnen zijn voor het analyseren van beelden bij het gebruik van OCT in de 
klinische praktijk.
In hoofdstuk 6 presenteren we de eerste lange-termijn in-vivo OC- data 5 jaar na BVS-implantatie. 
De verzwakkingskaarten en IPA bleken potentiële klinische onderzoeksmethoden die plaque passiviteit 
kunnen aantonen, inclusief de formatie van een potentiële beschermende ‘sealing layer’ tijdens de lange-
termijn BVS follow-up.
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In hoofdstuk 7, voerden we een uitgebreide OCT-analyse uit op patiënt-niveau en segment-niveau van 
‘non-culprit’ plaque morfologie, om zo de dynamische veranderingen van coronaire atherosclerose 
onder standaard medische therapie te evalueren. We hebben ook een kwantitatieve verzwakkingsanalyse 
gedaan om de bevindingen van de plaque typering te bevestigen. De studie liet een goede relatie 
tussen plaque veranderingen en weefsel type, geïdentificeerd door verzwakking, zien. IPA is niet een 
onafhankelijke voorspeller, maar is gecorreleerd met plaque type, welke in relatie staat met verandering.
We bestuurden de relatie tussen plaque-vrije vaatwand (PFW), gemeten op OCT-beelden, en de plaque 
grootte (PB), gemeten op IVUS-beelden, in hoofdstuk 8. PFW-hoek gemeten door OCT is een goede 
voorspeller voor de PB en verhoogd dus de haalbaarheid van het gebruik van alleen OCT-katheters, in 
plaats van een combinatie met IVUS tijdens een stent procedure. Hiermee kunnen het risico voor de 
patiënt, de lengte van de procedure en de kosten worden teruggebracht.
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